<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20220802</date><key>pmc.key</key><document><id>9326261</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.3389/fnint.2022.756604</infon><infon key="article-id_pmc">9326261</infon><infon key="article-id_pmid">35910337</infon><infon key="elocation-id">756604</infon><infon key="kwd">ACE2 COVID-19 multi-data integration neurological symptom SARS-CoV-2 TMPRSS2 LinkRbrain</infon><infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</infon><infon key="name_0">surname:Mesmoudi;given-names:Salma</infon><infon key="name_1">surname:Lapina;given-names:Colline</infon><infon key="name_2">surname:Rodic;given-names:Mathieu</infon><infon key="name_3">surname:Peschanski;given-names:Denis</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">16</infon><infon key="year">2022</infon><offset>0</offset><text>Multi-Data Integration Towards a Global Understanding of the Neurological Impact of Human Brain Severe Acute Respiratory Syndrome Coronavirus 2 Infection</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>154</offset><text>As the COVID-19 pandemic continues to unfold, numerous neurological symptoms emerge. The literature reports more and more manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) related to headache, dizziness, impaired consciousness, cognitive impairment, and motor disorders. Moreover, the infection of SARS-CoV-2 may have a durable neurological impact. ACE2/TMPRSS2 is the main entry point into cells for some strains of coronaviruses (CoVs), including SARS-CoV-2, which uses it to target the central nervous system (CNS). The aim of this study was to characterize the scope of the potential complex impact of a SARS-CoV-2 infection in the brain. It concerns different scales: the topographic, cognitive, sensorimotor, and genetic one. We investigated which cognitive and sensorimotor functions are associated with the brain regions where ACE2/TMPRSS2 is overexpressed, hypothesising that they might be particularly affected by the infection. Furthermore, overexpressed genes in these regions are likely to be impacted by COVID-19. This general understanding is crucial to establish the potential neurological manifestations of the infection. Data on mRNA expression levels of genes were provided by the Allen Institute for Brain Science (AIBS), and the localisation of brain functions by the LinkRbrain platform. The latter was also used to analyze the spatial overlap between ACE2/TMPRSS2 overexpression, and either function-specific brain activations or regional overexpression of other genes. The characterisation of these overexpressed genes was based on the GeneCards platform and the gene GSE164332 from the Gene Expression Omnibus database. We analysed the cognitive and sensorimotor functions whose role might be impaired, of which 88 have been categorised into seven groups: memory and recollection, motor function, pain, lucidity, emotion, sensory, and reward. Furthermore, we categorised the genes showing a significant increase in concentration of their mRNAs in the same regions where ACE2/TMPRSS2 mRNA levels are the highest. Eleven groups emerged from a bibliographical research: neurodegenerative disease, immunity, inflammation, olfactory receptor, cancer/apoptosis, executive function, senses, ischemia, motor function, myelination, and dependence. The results of this exploration could be in relation to the neurological symptoms of COVID-19. Furthermore, some genes from peripheral blood are already considered as biomarker of COVID-19. This method could generate new hypotheses to explore the neurological manifestations of COVID-19.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2735</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2748</offset><text>Recently, an increasing number of neurological symptoms are reported in different COVID-19 studies. Among them, the most widely reported in humans are headache, dizziness, impaired consciousness, cognitive impairment, as well as motor disorders and neuropathic pain. Some studies suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects the brain of COVID-19 patients. Especially, autopsies revealed SARS-CoV-2 antigens in the brain parenchyma and cortical neurons of some patients. The SARS-CoV-2 viral RNA has been detected in the substantia nigra. In animal studies, it is suggested that dopaminergic neurons, cortical neurons, microglia, and astrocytes are susceptible to SARS-CoV-2 infection. This infection may have a durable neurological impact. Other studies established the hypothesis of a relation between a SARS-CoV-2 infection and some neurological diseases like Alzheimer’s, Parkinson’s, and dementia.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3696</offset><text>Angiotensin-converting enzyme 2 (ACE2), a novel homologous of ACE expressed in renal and cardiovascular tissues, as well as the gastrointestinal system, was reported to be the main receptor for SARS-CoV-2 entry into cells. In the brain, several studies indicated that ACE2 was expressed in excitatory and inhibitory neurons, astrocytes, and microglia in the human and mouse brain. demonstrated that SARS-CoV-2 also uses ACE2 to target the central nervous system (CNS). analysed diffusion tensor imaging and 3D high-resolution T1WI sequences of several COVID-19 patients and concluded that significant structural changes happen in different regions, such as olfactory cortices, hippocampi, insula, and cingulate gyrus. These structural changes correspond to brain regions where the gene coding for ACE2 is expressed the most. Therefore, biological, cognitive, and sensorimotor functions that characterize the regions where ACE2 is overexpressed are likely to be affected by the COVID-19.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4683</offset><text>In addition to ACE2, other works have reported the transmembrane serine protease 2 (TMPRSS2) gene as another potential entry of SARS-CoV-2 in several tissues, such as kidney and lung tissue. For the brain, the potential entry ACE2/TMPRSS2 of the virus has been studied in mice and humans and has been reported by, in GSE151973. Furthermore, in addition to the role of ACE2 and TMPRSS2 as an entry of the virus through the nasal tissue to the brain, several studies have linked their brain distribution to certain neurological effects of COVID-19.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5230</offset><text>Although the presence of SARS-CoV-2 in the CNS has been demonstrated, its mode of replication remains unclear. However, the results from modelling SARS-CoV-2 neuroinvasion and cell death using human brain organoids suggested that SARS-CoV-2 is able to use the machinery of neuronal cells to replicate. In addition, revealed that an average of 50% of infected mice exhibited CNS infection characterised by widespread viral replication in neurons.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5676</offset><text>The aim of this study was to characterize the scope of the potential complex impact of a SARS-CoV-2 infection in the brain. It concerns different scales: the topographic, cognitive, sensorimotor, and genetic one. This characterisation concerns the cognitive and sensorimotor functions, but also the local overexpressed genes. This general understanding is crucial to establish the potential neurological manifestations of the infection. Hypotheses were drawn using the genetic base of Allen Institute for Brain Science (AIBS), and the topographical distance was provided by the LinkRbrain platform. LinkRbrain is an open-access web tool for multi-scale integration of knowledge on the brain.1 It provides a visualisation of the literature about 460 cognitive and sensorimotor functions of each brain region and integrates this functional information with transcriptome data. The cognitive and sensorimotor database has been automatically extracted from the literature. AIBS atlas is used to cover 20,789 mRNA (messenger ribonucleic acid) expressions in the 947 human brain regions expressed by 947 Montreal Neurological Institute (MNI) coordinates. For each coordinate, the platform maps the cognitive and sensorimotor functions on a brain, as well as the expression scores of 20,789 mRNAs of genes. Based on its topographical calculation, LinkRbrain provides relational graphs of the functions and the genes. The final objective of this platform was to document the cognitive and sensorimotor functions and the genes of each brain coordinate thanks to the topographical similarities and co-expressions of mRNA.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>7288</offset><text>In this work, we especially aimed to document ACE2/TMPRSS2 by identifying the cognitive and sensorimotor functions that activate, separately, the same regions where ACE2 and TMPRSS2 are overexpressed, as well as the other genes co-overexpressed with ACE2 and TMPRSS2. To do so, we first detected and mapped the regions where the mRNAs of ACE2 and TMPRSS2 are overexpressed. Then, based on the topographical distance calculation, we found the cognitive and sensorimotor functions that activate these regions. Finally, we calculate the topographical distance between a specific mRNA (of ACE2 and TMPRSS2) and the localised overexpression of the 20,789 identified mRNAs. This allowed us to identify the most expressed genes in the regions where ACE2 (or TMPRSS2) is overexpressed. The results of this topographical exploration are coherent with observed COVID-19 neurological symptoms. This method could generate new hypotheses to explore the neurological manifestations of COVID-19.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>8269</offset><text>Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>8291</offset><text>Genomic Data Sources</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8312</offset><text>The Allen Brain Atlas (ABA), developed by the AIBS, provides a transcriptomic map of the whole human brain. RNAs were extracted from each brain to implement 58,693 complementary RNA hybridisation probes. The ABA dataset consists of two full post-mortem brains and four half brains. In this study, we are interested in the complete brain data H0351.2001 and H0351.2002. The genetic profiles of these two brains are highly similar. In addition, LinkRbrain used ABA H0351.2001, which presents the genetic profiles of a set of 947 samples. It represents the structures of the human brain in approximate proportion to the volumetric representation of each cortical, subcortical, cerebellar, and brainstem structure. In this study, all the genetic results are related to ABA H0351.2001.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>9093</offset><text>DNA Chip and Transcriptomic Map</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9125</offset><text>To obtain the genetic and topographical data of the brains studied by the AIBS, several steps of a process have been accomplished and they will be summarised in this section. Each brain studied was cooled and subjected to magnetic resonance imaging (MRI) of the skull, followed by embedding, smashing, and freezing. Cry sections of the entire brain were performed from each plate, after which the plates were subdivided and sectioned on 2 × 3 inch slides for histological analysis to identify the structure. Defined areas of the brain were isolated either by macrodissection (cortical gyri, other large structures) or laser microdissection (Leica LMD6000, Leica Microsystems) from tissue sections on polyethylene naphthalate membrane slides. Any given anatomical structure was first identified on the basis of histological data and then sampled from a series of contiguous coronal plates in both hemispheres. RNA was isolated from each sample and used to generate complementary RNA or complementary RNA (cRNA) probes (approximately 50,000 probes per brain) labelled for hybridisation with customised Agilent 64K microarrays.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10251</offset><text>Each sample was then placed back into the cortical space using functional MRI data and assigned MNI coordinates. A total of 1,000 MNI coordinates were characterised using concentration rates of approximately 20,789 RNAs.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>10472</offset><text>Cognitive and Sensorimotor Data Sources</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10512</offset><text>LinkRbrain relies on the database of activation peaks generated by the Neurosynth framework2. It contains 194,387 activation peaks automatically extracted with text mining from over 14,000 published neuroimaging papers, with 140,974 coordinates correctly labelled in Talairach or MNI. To extract the terms used by authors to describe the cognitive and sensorimotor functions, we used the abstracts and titles of the neuroimaging articles contained in the Neurosynth database.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10988</offset><text>The unique relation linking the cognitive and sensorimotor functions is the topographical relations that can be estimated by quantifying the spatial overlap between task-related activations for different functions. In this work, we focus on topographical relations between the functions, the genetic expression profiles, and the neuroanatomical structures. We used a lexical extraction to identify a set of pertinent terms. Text processing involves both grammatical and statistical phases to automatically extract candidate n-grams (also called multi-terms). We analysed the textual content found in titles and abstracts of the 14,000 papers within Neurosynth. The most pertinent noun phrases in our corpus were then curated by a neuroscientist who manually selected the 460 most frequent cognitive and sensorimotor functions. This curation operation simply consists in eliminating n-grams without any relation to cognitive and sensorimotor tasks. In order to link the activation peaks and the function labels, Neurosynth data and software were used to generate a meta-analytic reverse inference map for each of the previously extracted n-grams. This map quantifies the degree to which each brain region is preferentially activated in studies tagged with a particular cognitive and sensorimotor functions label. We use the map inference procedure to generate cognitive and sensorimotor networks from the activation peaks.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>12410</offset><text>LinkRbrain Topographical Distance</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>12444</offset><text>The topographical overlap (i.e., correlation) between gene expression regions and cognitive and sensorimotor activations is expressed as a distance based on a correlation metric.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>12623</offset><text>All calculations are based on the differential expression rate of genes in different brain regions. Gene expression region is a set of points or nodes. Given two nodes A and B (sets of weighted points), we can represent them as such:</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>12857</offset><text>where μi and νj are the weights of the two points Mi and Nj, respectively. The weights express genetic expression values related to the regions. “m” and “n” are the number of points in the sets A and B. The minimum number of points is 12 (coordination task set), and 23079 is the maximum number of points (memory task set).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>13191</offset><text>The correlation score (σ) between the nodes A and B is defined by the formula:</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>13274</offset><text>where r is the reference radius (10 mm in this case, consistent with the meta-analysis), and d(Mi,Nj) is the Euclidian distance between Mi and Nj.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>13421</offset><text>The Euclidian distance is calculated by the formula:</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>13474</offset><text>The final score between A and B is obtained after normalising the correlation scores.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>13560</offset><text>For readability purposes, this result is displayed as multiplied by 100, which is then rounded to the nearest integer.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>13679</offset><text>The correlation between the selected function(s), gene(s), or neuroanatomical regions and the other functions, genes, or neuroanatomical regions can be represented as a graph. The graph is computed using the force-directed layout algorithm.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>13920</offset><text>Analysis From the LinkRbrain Platform</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>13958</offset><text>LinkRbrain is an open-access web platform integrating anatomical, functional, and genetic knowledge provided by the scientific community (see text footnote 1). As explained above, the genetic data were provided by the AIBS, and the cognitive and sensorimotor functions have been automatically extracted from the literature.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14282</offset><text>The topographical distance described in the previous paragraph has been used to evaluate spatial correlations between the brain areas where mRNAs of ACE2 or TMPRSS2 (separately) are overexpressed, and the localised overexpression of 20,789 identified mRNAs.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14540</offset><text>The platform allows the comparison of new sets of coordinates with previously published articles. Thus, the insertion of gene names in the platform allows their visualisation as a new set of coordinates. In addition, it establishes correlations with other genes whose level of expression is already identified at the same location.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>14872</offset><text>Furthermore, the platform incorporates a database of cognitive and sensorimotor functions with their coordinates, corresponding to the peaks of brain activation. This allows topographical interactions to be made by calculating the correlations on the overlap between the different activated zones and the localisations of the functions.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>15209</offset><text>Complementary Databases</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15233</offset><text>In order to identify biological functions and pathways, and to compare our results with the immune signature enrichment levels in peripheral blood and brain, we used the following:</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15414</offset><text>The human gene database GeneCards available at https://www.genecards.org/.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15489</offset><text>The Gene Expression Omnibus (GEO) data using SARS-CoV-2 as the keyword.3 Especially the section SARS-CoV-2 and COVID-19 pathway (WP4846).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15627</offset><text>The exploration results of expression profiling by high-throughput sequencing of GSE164485 and GSE164332 from the Gene Expression Omnibus database.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>15775</offset><text>Visualisations</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15790</offset><text>Thanks to the tools available on LinkRbrain we obtained:</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>15847</offset><text>3D and 2D visualisations: allow to envision the coordinates of the different transcription levels of ACE2 and TMPRSS2 mRNAs. On each 3D representation, zero coordinates appear at the crossing of vertical and horizontal lines.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>16073</offset><text>Topographical correlation graphs: illustrate the 20 most closely correlated cognitive and sensorimotor functions with ACE2 or TMPRSS2.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>16208</offset><text>List of cognitive and sensorimotor functions: based on its topographical distance calculation, LinkRbrain provides among 460 cognitive and sensorimotor functions the ones that activate the same topographical localisations where the ACE2 and TMPRSS2 mRNAs are highly expressed.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>16485</offset><text>List of genes: based on its topographical distance calculation, LinkRbrain provides among 20,789 mRNA gene expressions a list of mRNAs which share the highest co-expression with the ACE2 and TMPRSS2 mRNAs.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>16691</offset><text>Data Availability</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>16709</offset><text>The topographical data that support a part of the findings of this study are the regions of the Talairach atlas openly available at http://www.talairach.org/index.html.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>16878</offset><text>LinkRbrain relies on the database of activation peaks generated by the Neurosynth framework: http://neurosynth.org. The localisation of the cognitive and sensorimotor functions available on LinkRbrain has been automatically extracted with text mining from over 14,000 published neuroimaging papers, with 140,974 coordinates correctly labelled in Talairach or MNI.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>17242</offset><text>The data on mRNA expression levels of genes were provided by the AIBS, which shared their human brain genetic data available at https://human.brain-map.org/.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>17400</offset><text>Thanks to LinkRbrain’s topographical distance calculation, we analysed the correlation between ACE2 overexpression, and either region-specific brain activation, function-specific brain activations, or regional overexpression of other genes. The authors confirm that the lists of regions, functions, and genes found with this correlation are available in Supplementary Tables 1–4.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>17784</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17792</offset><text>In this study, we executed several stages of the LinkRbrain process. First, we started by mapping the regions where the ACE2 mRNAs are overexpressed in the brain thanks to ABA H0351.2001. Then, we used the topographical distance calculated by LinkRbrain to identify the main brain functions activating the same regions where the ACE2 mRNAs are the most overexpressed. Finally, we identified the other mRNAs that could be co-overexpressed in the same regions of ACE2 mRNAs.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18265</offset><text>A correlation based on the topographical distance calculates the intersection between two groups of points. Each group represents brain functions or genes, and the points are the activations or AIBS coordinates. This intersection between the groups respects the normalisation of the group sizes; thus the higher correlation indicates a higher intersection between the groups.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>18641</offset><text>Visualisation of Angiotensin-Converting Enzyme 2 Overexpression</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18705</offset><text>Representative points of ACE2 and TMPRSS2 are mapped on LinkRbrain on a 3D and 2D representations of the human brain cortical surface (see Figure 1). The LinkRbrain platform listed the main regions where ACE2 and TMPRSS2 mRNAs are overexpressed (see the list in Supplementary Table 1). The first observation was that ACE2 and TMPRSS2 are predominantly overexpressed in the same regions. We can find the brain stem and some regions from the subcortical, such as putamen, caudate, amygdala, insula, hippocampus, and thalamus. Other cortical regions are also detected: the temporal gyrus, the orbitofrontal lobe (BA10 and BA11), and some occipital regions.</text></passage><passage><infon key="file">fnint-16-756604-g001.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>19359</offset><text>2D and 3D visualisations of ACE2 (in blue) and TMPRSS2 (in magenta) mRNA overexpressions in the brain. The differences in 3D visualisation color intensity result from the transparency of the brain and the juxtaposition of several layers.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>19597</offset><text>Potential Cognitive and Sensorimotor Functions Affected by Severe Acute Respiratory Syndrome Coronavirus 2</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19704</offset><text>LinkRbrain incorporates a database of cognitive and sensorimotor functions with their coordinates corresponding to their brain activation peaks.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19849</offset><text>The results of this topographical exploration present some interesting outcomes. For each gene (ACE2/TMPRSS2), we analysed a group of the 100 most correlated functions. As expected, 93% of the functions are identical between the two groups. After merging the two functions groups, the resulting 107 functions whose role might be impaired, of which 104 are categorised into seven groups that could be in relation to the neurological symptoms of COVID-19 (see Table 1).</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>20317</offset><text>Cognitive and sensorimotor functions activating the same regions where ACE2/TMPRSS2 mRNAs are overexpressed, clustered by groups.</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot; cellspacing=&quot;5&quot; cellpadding=&quot;5&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Memory and recollection&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Motor function&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pain&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Lucidity&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Emotion&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sensory&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Reward&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;memory&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;rapid eye movement&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;pain perception&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;alertness&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;emotional modulation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;visuomotor control&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;reward&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;episodic memory&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ankle&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;pain intensity&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;navigation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;fear conditioning&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;complex visual scenes&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;reward processing&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;recall&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;movement execution&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;evoked pain&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;visuospatial task&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;disgust&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;auditory discrimination&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;monetary rewards&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;visuospatial working memory&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;finger movements&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;painful stimuli&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;anticipation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;pleasure&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;sensorimotor integration&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;rewarded responses&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;associative memory&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;motor function&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;pain control&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;task execution&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;fear&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;odour&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;rewarding stimuli&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;consolidation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;movement sequences&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;pain unpleasantness&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;top down attentional control&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;fearful expressions&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;somatosensory stimulation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;memory storage&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;overt speech&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;non-painful&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;goal directed action&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;love&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;spatial memory&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;leg&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;phasic pain&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;mental rotation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;disgust and fear&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;emotional memories&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;motor control&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pain representation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;higher order cognitive&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;facial expressions of disgust&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;memory processes&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;motor performance&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;divided attention&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;aggression&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;short term memory&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;bimanual coordination&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;imagination&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;unpleasant stimuli&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;semantic retrieval task&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;muscle activity&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;introspection&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;pleasantness&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;false recognition&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;flexion&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;serial order&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;threat&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;familiarity&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;limb&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;sequence learning&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;aversive stimuli&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;subsequent recognition&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;left foot&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;semantic integration&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;noxious stimulus&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;declarative memory&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;right hand&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;interoceptive awareness&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;danger&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;explicit memory&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;foot movements&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;movement complexity&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;passive movement&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;grip force&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;motor programs&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;simple motor task&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;left hand&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;movement initiation&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;wrist&lt;/td&gt;&lt;td rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>20447</offset><text>Memory and recollection	Motor function	Pain	Lucidity	Emotion	Sensory	Reward	 	memory	rapid eye movement	pain perception	alertness	emotional modulation	visuomotor control	reward	 	episodic memory	ankle	pain intensity	navigation	fear conditioning	complex visual scenes	reward processing	 	recall	movement execution	evoked pain	visuospatial task	disgust	auditory discrimination	monetary rewards	 	visuospatial working memory	finger movements	painful stimuli	anticipation	pleasure	sensorimotor integration	rewarded responses	 	associative memory	motor function	pain control	task execution	fear	odour	rewarding stimuli	 	consolidation	movement sequences	pain unpleasantness	top down attentional control	fearful expressions	somatosensory stimulation		 	memory storage	overt speech	non-painful	goal directed action	love			 	spatial memory	leg	phasic pain	mental rotation	disgust and fear			 	emotional memories	motor control	Pain representation	higher order cognitive	facial expressions of disgust			 	memory processes	motor performance		divided attention	aggression			 	short term memory	bimanual coordination		imagination	unpleasant stimuli			 	semantic retrieval task	muscle activity		introspection	pleasantness			 	false recognition	flexion		serial order	threat			 	familiarity	limb		sequence learning	aversive stimuli			 	subsequent recognition	left foot		semantic integration	noxious stimulus			 	declarative memory	right hand		interoceptive awareness	danger			 	explicit memory	foot movements						 		movement complexity						 		passive movement						 		grip force						 		motor programs						 		simple motor task						 		left hand						 		movement initiation						 		wrist						 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>22129</offset><text>The first group consists of 17 functions, all related to memory and recollection. Among them are “semantic retrieval task” and “false memory” with one of the highest correlations to ACE2/TMPRSS2. The second group consists of 25 functions connected with motor functions, such as “movement execution,” “movement sequences,” and “motor control,” which can be found in Figure 2. Another group is represented by eight functions and concerns physical and mental suffering, and pain is highly present in the results. The highest scores of correlations are found for “pain perception,” “pain intensity,” and “evoked pain.” For the next group, 16 functions related to the lucidity filling have been grouped. As the COVID-19 pandemic continues to unfold, numerous neurological symptoms are coming to light, among which is the feeling of confusion. The fifth group consists of 16 functions associated with emotional intensity and modulation. Finally, five functions concerning sensory inputs like visual, auditory, and odor tasks have been found in our results.</text></passage><passage><infon key="file">fnint-16-756604-g002.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>23212</offset><text>Graphs portraying the regions where the ACE2 (in blue) and TMPRSS2 (in magenta) are the overexpressed and their highest correlated functions. The blue or magenta links connect “ACE2” or “TMPRSS2” network with their correlated tasks. The gray links connect tasks with each other. Each graph shows the 20 most correlated functions/regions. The complete lists of functions and regions are in the Supplementary Materials.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>23638</offset><text>Potential Genes Affected by Severe Acute Respiratory Syndrome Coronavirus 2</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>23714</offset><text>The other objective of this work was to explore the genes with mRNAs overexpressed in the same regions as ACE2 and TMPRSS2. LinkRbrain computed correlations between region coordinates where ACE2 mRNAs have the highest expression levels and the coordinates of the overexpression of each of the 20,788 genes on the platform. The same process was applied toTMPRSS2 mRNAs. From this calculation, and for each studied gene RANm (ACE2/TMPRSS2), 100 genes showed a significant increase in concentration of their mRNAs in the same regions where ACE2 or TMPRSS2 mRNA levels are the highest (see the list in Supplementary Table 3).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>24336</offset><text>It has been established by that SARS-CoV-2 brain infection altered some brain regions. These topographical changes could cause gene transcription perturbations. The results related to the overexpression of mRNA genes, as well as the work presented in this study, are not definitive. All these results have to be used as a possible field to explore.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>24685</offset><text>After merging the two ACE2/TMPRSS2 correlated mRNA groups, we obtained 179 unique genes. From these identified 179 genes, 98 were clustered into 11 groups (see Table 2). Considering their cellular and biological functions, this clusterisation was based on GeneCards platform and bibliographic research.</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>24988</offset><text>Genes co-expressed with ACE2/TMPRSS2, clustered by groups.</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot; cellspacing=&quot;5&quot; cellpadding=&quot;5&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Neurodegenerative disease and behaviour&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Immunity&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Inflammation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Olfactory receptor&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cancer/Apoptosis&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Executive function&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sennses&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ischemia&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Motor function&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Myelination&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dependence&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;ASB14&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;GRAP2&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;CPA2&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;OR10G7&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;AADACL3&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;DSG1&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;USH2A&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;REST&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;CFTR&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;AADACL3&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;DNASE2B&lt;/italic&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;HIST1H2BJ&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;RNASE9&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;CSF3&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;OR12D2&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;MAFIP&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;ERLIN2&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;STRA8&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;NOS3&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;ERLIN2&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;FRK&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;DNAH3&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;AADACL3&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;NA&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;OR2J3&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;CASC2&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;WDR72&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;PNLIPRP3&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;KCNK5&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;GCH1&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;TSLP&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;HTR3C&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;TRIM60&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;KLRK1&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;OR4C46&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;OSMR&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;TSIX&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;TMC2&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;CSF3&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;USH2A&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;HEPACAM2&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;CASC2&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;SPRYD5&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;IL5RA&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;OR5B2&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;MXRA5&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;REST&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;KCNK5&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FGA&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;ITLN2&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;IKZF3&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;CMA1&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;FRK&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;OR11H4&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;RBMY1A3P&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GPR110&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TRIM55&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;HYAL4&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;KCNK5&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;E2F8&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;OR8H3&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;TP53&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FRMD7&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;F2RL3&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;TAS2R1&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;KLRF1&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;GCH1&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;CNGA4&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CD248&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CLDN14&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;SP140&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;SP140&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TRIM55&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;XAGE3&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GJB3&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;ZFP42&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;CD79B&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MEP1B&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NCR1&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TMC3&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;CMA1&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;SEMG1&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IL18RAP&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HES2&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CST9L&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;LRP6&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;IFNA16&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;STX11&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MACC1&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;KIAA1161&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;MUC17&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NOXO1&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FGF23&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;HGD&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;SLAMF9&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;LGALS17A&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MUC16&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;GCH1&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;LYZ&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;F2RL3&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CHST4&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;FRK&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;GPR84&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IL22RA2&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ANAPC1&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;NA&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;IL4&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PDCD1LG2&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;DSG1&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;IL28B&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TERT&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;LYZ&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;CXCR6&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ZNF705D&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;AGBL3&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DIO1&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;UNC93A&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CAPN9&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;C4BPA&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GPR84&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;GOLGA6L2&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;UBTFL1&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;IL25&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ALDH3A1&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;CD180&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;VDR&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;FCAMR&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NOXO1&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;PDCD1LG2&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;DPEP1&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;APOL5&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;SKA1&lt;/italic&gt;
&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>25047</offset><text>Neurodegenerative disease and behaviour	Immunity	Inflammation	Olfactory receptor	Cancer/Apoptosis	Executive function	Sennses	Ischemia	Motor function	Myelination	Dependence	 	ASB14	GRAP2	CPA2	OR10G7	AADACL3	DSG1	USH2A	REST	CFTR	AADACL3	DNASE2B	 	HIST1H2BJ	RNASE9	CSF3	OR12D2	MAFIP	ERLIN2	STRA8	NOS3	ERLIN2	FRK		 	DNAH3	AADACL3	NA	OR2J3	CASC2	WDR72	PNLIPRP3	KCNK5	GCH1	TSLP		 	HTR3C	TRIM60	KLRK1	OR4C46	OSMR	TSIX	TMC2	CSF3	USH2A	HEPACAM2		 	CASC2	SPRYD5	IL5RA	OR5B2	MXRA5	REST	KCNK5	FGA		ITLN2		 	IKZF3	CMA1	FRK	OR11H4	RBMY1A3P		GPR110	TRIM55				 	HYAL4	KCNK5	E2F8	OR8H3	TP53		FRMD7	F2RL3				 	TAS2R1	KLRF1	GCH1	CNGA4	CD248		CLDN14					 	SP140	SP140	TRIM55		XAGE3		GJB3					 	ZFP42	CD79B	MEP1B		NCR1		TMC3					 	CMA1	SEMG1	IL18RAP		HES2		CST9L					 	LRP6	IFNA16	STX11		MACC1							 	KIAA1161	MUC17	NOXO1		FGF23							 	HGD	SLAMF9	LGALS17A		MUC16							 	GCH1	LYZ	F2RL3		CHST4							 	FRK	GPR84	IL22RA2		ANAPC1							 	NA	IL4			PDCD1LG2							 	DSG1	IL28B			TERT							 	LYZ	CXCR6										 	ZNF705D	AGBL3										 	DIO1	UNC93A										 	CAPN9	C4BPA										 	GPR84	GOLGA6L2										 	UBTFL1	IL25										 	ALDH3A1	CD180										 	VDR	FCAMR										 	NOXO1	PDCD1LG2										 		DPEP1										 		APOL5										 		SKA1										 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>26282</offset><text>In Table 2, we identified eight genes coding for olfactory receptors (ORs), such as OR10H1, OR52B6, and OR8S1. Moreover, genes that could be related to inflammation, myelination, immunity, ischemia, and cancer genes have been found, such as CPA2, AADACL3, GRAP2, and REST. The characterisation of these groups naturally leads to the emergence of a cluster composed of genes related to neurodegenerative diseases, such as Alzheimer’s and Parkinson’s diseases. These two diseases do not appear to be the only ones worsening neuroinflammation and decreasing cognitive function as other diseases seem to be correlated with SARS-CoV-2 like dementia. Finally, we found that the AIPL1 and TMC2 genes are related to vision, hearing, and equilibrium perturbations.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>27042</offset><text>In Table 3, we explored the pathways that involved some genes corresponding to the co-expressed mRNAs. We obtained results concerning pathways implicated in apoptosis process, immune system, and also in glycosylation.</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>27260</offset><text>Pathways where our co-expressed mRNA are involved.</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot; cellspacing=&quot;5&quot; cellpadding=&quot;5&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pathways&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Genes&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Keratinization and developmental biology&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;KRTAP13-2, KRT23, KRT28, PRDM14&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Signalling by Rho GTPases and cell cycle&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CENPA, NOXO1, SKA1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Coagulation pathway&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FGA&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Immune response IFN alpha/beta signalling pathway&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IFNA16, IL4, IL28B&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PI3K/Akt signalling and tyrosine kinases/adaptors&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MACC1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Defective GALNT12 causes colorectal cancer 1 (CRCS1)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MUC17, MUC16&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;RNA Polymerase I Promoter Opening and Macrophage markers&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;LYZ&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Transport glucose, diseases of glycosylation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MUC17, BEST2, MUC16, LDHAL6B, FXYD3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Innate immune system&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CLDN14, GPR84, C4BPA, PDCD1LG2, IL22RA2, DSG1, KLRF1, TRIM38&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Signalling by GPCR&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GPR84, CXCR6, CST9L, NMUR2, NOXO1, OR2J3, CMA1, TAS2R1, OR5B2, OR10G7, OR11H4, C3AR1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Downstream signalling of activated FGFR2&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FGF23&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Phospholipase-C pathway&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FGF23, GRAP2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Metapathway biotransformation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ALDH3A1, UGT2A3, DPEP1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Cyclophosphamide pathway, pharmacodynamics&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ALDH3A1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Nuclear receptors in lipid metabolism and toxicity and gene expression gene expression&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;VDR&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ERK signalling&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IL4, ROR2, PTK7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Peginterferon alpha-2a/peginterferon alpha-2b pathway (Hepatocyte), pharmacodynamics&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IL28B&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Toll-like receptor signalling pathways&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IL28B, CD180&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Peptide ligand-binding receptors&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CXCR6, GPHB5, CST9L, NMUR2, F2RL3, OR2J3, TAS2R1, GRM6, C3AR1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Creation of C4 and C2 activators&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;C4BPA, C9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Activation of cAMP-dependent PKA&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MEP1B, PTK7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Signal transduction_PKA signalling signal transduction_PKA signalling&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MEP1B&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Immune response IL-23 signalling pathway and IL12 signalling mediated by STAT4IL12 signalling mediated by STAT4&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IL18RAP&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Metabolism of proteins&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CHST4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;O-linked glycosylation of mucins&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CHST4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Development and heterogeneity of the ILC family and IL-17 family signalling pathways&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IL25&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Activated TLR4 signalling&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CD180&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Response to elevated platelet cytosolic Ca2+ and cell surface interactions at the vascular wall.&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FCAMR&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Class I MHC mediated antigen processing&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PDCD1LG2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Complement pathway&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;C9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Apoptotic cleavage of cellular proteins&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DSG1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Apoptotic pathways in synovial fibroblasts&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TERT&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Apoptosis and autophagy and ATF-2 transcription factor network&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SERPINB5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Signalling by Wnt&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TERT ROR2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Nicotine pathway (dopaminergic neuron), pharmacodynamics&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;STX11&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Triacylglycerol degradation and lipoprotein metabolism&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PNLIPRP3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Glucuronidation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;UGT2A3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Transport of mature transcript to cytoplasm and cleavage of growing transcript in the termination region&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;LUZP4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; G-AlphaQ signalling&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;F2RL3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TGF-beta pathway&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IL22RA2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Eicosanoid synthesis&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DPEP1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cholesterol and sphingolipids transport&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;APOL5 APOL4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Recycling to plasma membrane in lung (normal and CF)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;APOL5 APOL4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Statin pathway–generalised, pharmacokinetics, and farnesoid X receptor&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ABCB11&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Neuropathic pain-signalling in dorsal horn neurons&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;KCNK5, GRM6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sweet taste signalling&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;KCNK5, CNGA4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Pyruvate metabolism and citric acid (TCA) cycle&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;LDHAL6B&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Immune response_Oncostatin M signalling &lt;italic&gt;via&lt;/italic&gt; JAK-Stat in human cells&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;OSMR&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;G-protein signalling Ras family GTPases in kinase cascades (scheme)&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;OSMR&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Class I MHC mediated antigen processing and presentation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;KLRF1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CREB pathway and ion channel transport&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HTR3C FXYD3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Regulation of TP53 activity and DNA damage response (only ATM dependent).&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TP53&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Aminoglycoside ototoxicity pathway, adverse drug reaction&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TMC2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; IL-2 signalling pathway and NF-kappaB signalling&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IKZF3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Organelle biogenesis and maintenance&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CNGA4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;JNK signalling in the CD4+ TCR&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GRAP2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Histidine, lysine, phenylalanine, tyrosine, proline, and tryptophan catabolism and amino acid metabolism&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HAL, HGD&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Articular cartilage extracellular matrix&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HYAL4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Embryonic and induced pluripotent stem cells and lineage-specific markers and cardiac progenitor differentiation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ZFP42&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Transport of glucose and other sugars, bile salts and organic acids, metal ions, and amine compounds&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;FXYD3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Development and heterogeneity of the ILC family and innate lymphoid cells differentiation&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TSLP&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Integrin pathway and phospholipase-C pathway. LM&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;LAMC2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Development slit-robo signalling and G-beta gamma signalling&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GJB3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt; Interferon gamma signalling&lt;/td&gt;&lt;td valign=&quot;top&quot; align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TRIM38&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>27311</offset><text>Pathways	Genes	 	Keratinization and developmental biology	KRTAP13-2, KRT23, KRT28, PRDM14	 	Signalling by Rho GTPases and cell cycle	CENPA, NOXO1, SKA1	 	Coagulation pathway	FGA	 	Immune response IFN alpha/beta signalling pathway	IFNA16, IL4, IL28B	 	PI3K/Akt signalling and tyrosine kinases/adaptors	MACC1	 	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	MUC17, MUC16	 	RNA Polymerase I Promoter Opening and Macrophage markers	LYZ	 	Transport glucose, diseases of glycosylation	MUC17, BEST2, MUC16, LDHAL6B, FXYD3	 	Innate immune system	CLDN14, GPR84, C4BPA, PDCD1LG2, IL22RA2, DSG1, KLRF1, TRIM38	 	Signalling by GPCR	GPR84, CXCR6, CST9L, NMUR2, NOXO1, OR2J3, CMA1, TAS2R1, OR5B2, OR10G7, OR11H4, C3AR1	 	 Downstream signalling of activated FGFR2	FGF23	 	Phospholipase-C pathway	FGF23, GRAP2	 	Metapathway biotransformation	ALDH3A1, UGT2A3, DPEP1	 	 Cyclophosphamide pathway, pharmacodynamics	ALDH3A1	 	Nuclear receptors in lipid metabolism and toxicity and gene expression gene expression	VDR	 	ERK signalling	IL4, ROR2, PTK7	 	Peginterferon alpha-2a/peginterferon alpha-2b pathway (Hepatocyte), pharmacodynamics	IL28B	 	Toll-like receptor signalling pathways	IL28B, CD180	 	Peptide ligand-binding receptors	CXCR6, GPHB5, CST9L, NMUR2, F2RL3, OR2J3, TAS2R1, GRM6, C3AR1	 	 Creation of C4 and C2 activators	C4BPA, C9	 	Activation of cAMP-dependent PKA	MEP1B, PTK7	 	Signal transduction_PKA signalling signal transduction_PKA signalling	MEP1B	 	Immune response IL-23 signalling pathway and IL12 signalling mediated by STAT4IL12 signalling mediated by STAT4	IL18RAP	 	Metabolism of proteins	CHST4	 	O-linked glycosylation of mucins	CHST4	 	Development and heterogeneity of the ILC family and IL-17 family signalling pathways	IL25	 	Activated TLR4 signalling	CD180	 	 Response to elevated platelet cytosolic Ca2+ and cell surface interactions at the vascular wall.	FCAMR	 	Class I MHC mediated antigen processing	PDCD1LG2	 	Complement pathway	C9	 	 Apoptotic cleavage of cellular proteins	DSG1	 	Apoptotic pathways in synovial fibroblasts	TERT	 	 Apoptosis and autophagy and ATF-2 transcription factor network	SERPINB5	 	 Signalling by Wnt	TERT ROR2	 	 Nicotine pathway (dopaminergic neuron), pharmacodynamics	STX11	 	 Triacylglycerol degradation and lipoprotein metabolism	PNLIPRP3	 	 Glucuronidation	UGT2A3	 	 Transport of mature transcript to cytoplasm and cleavage of growing transcript in the termination region	LUZP4	 	 G-AlphaQ signalling	F2RL3	 	TGF-beta pathway	IL22RA2	 	Eicosanoid synthesis	DPEP1	 	Cholesterol and sphingolipids transport	APOL5 APOL4	 	Recycling to plasma membrane in lung (normal and CF)	APOL5 APOL4	 	 Statin pathway–generalised, pharmacokinetics, and farnesoid X receptor	ABCB11	 	 Neuropathic pain-signalling in dorsal horn neurons	KCNK5, GRM6	 	Sweet taste signalling	KCNK5, CNGA4	 	 Pyruvate metabolism and citric acid (TCA) cycle	LDHAL6B	 	 Immune response_Oncostatin M signalling via JAK-Stat in human cells	OSMR	 	G-protein signalling Ras family GTPases in kinase cascades (scheme)	OSMR	 	 Class I MHC mediated antigen processing and presentation	KLRF1	 	CREB pathway and ion channel transport	HTR3C FXYD3	 	 Regulation of TP53 activity and DNA damage response (only ATM dependent).	TP53	 	 Aminoglycoside ototoxicity pathway, adverse drug reaction	TMC2	 	 IL-2 signalling pathway and NF-kappaB signalling	IKZF3	 	 Organelle biogenesis and maintenance	CNGA4	 	JNK signalling in the CD4+ TCR	GRAP2	 	Histidine, lysine, phenylalanine, tyrosine, proline, and tryptophan catabolism and amino acid metabolism	HAL, HGD	 	 Articular cartilage extracellular matrix	HYAL4	 	 Embryonic and induced pluripotent stem cells and lineage-specific markers and cardiac progenitor differentiation	ZFP42	 	Transport of glucose and other sugars, bile salts and organic acids, metal ions, and amine compounds	FXYD3	 	Development and heterogeneity of the ILC family and innate lymphoid cells differentiation	TSLP	 	Integrin pathway and phospholipase-C pathway. LM	LAMC2	 	Development slit-robo signalling and G-beta gamma signalling	GJB3	 	 Interferon gamma signalling	TRIM38	 	</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>31436</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>31447</offset><text>The aim of this study was to characterize the scope of the potential complex impact of a SARS-CoV-2 infection in the brain. LinkRbrain contains three databases: Talairach atlas of topographical regions, 460 cognitive and sensorimotor functions, and mRNAs gene expression. Each of these databases consists of MNI coordinates related to one or several labels. Depending on the scale, the label(s) will be topographical, cognitive and sensorimotor, or genetic. We started by mapping the regions where ACE2 and MPRSS2 mRNAs are overexpressed thanks to the mRNA expression levels of genes provided by the AIBS. Then, thanks to LinkRbrain’s topographical distance calculation, we analysed the correlation between ACE2 and MPRSS2 overexpression, and either region-specific brain activation, function-specific brain activations, or regional overexpression of other genes. The results of this integration brought to light seven cognitive and sensorimotor categories and 11 genetic groups. The main regions specific to ACE2 and MPRSS2 that we found are localised in the brain stem, the subcortical, the orbitofrontal, and some occipital regions. This is coherent with the literature study of where the spatial distribution analysis demonstrated that the expression of ACE2 and MPRSS2 is relatively high in specific brain locations, such as thalamus, human middle temporal gyrus, posterior cingulate cortex, and hippocampal. Thanks to the correlation calculated by LinkRbrain, it was established that 88 cognitive and sensorimotor functions activate these regions.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>33003</offset><text>The first group consists of 15 functions, all related to memory and recollection. This suggests that COVID-19 could lead to memory complications. In fact, some studies show that SARS-CoV-2 infection entails a cytokine storm, which can later generate cognitive and psychiatric effects. suggest that memory and concentration problems noticed after the infection are related to the significant structural changes occurred in some specific brain regions. Patients endured decreased concentration, reduced memory, and difficulty retaining information, persisting for over 2 months. Several studies described cognitive impairment in patients infected by SARS-CoV-2. demonstrated that 80% of patients presented cognitive deficits, when mentioned deterioration in attention, memory, and executive functions. The second group consists of 25 functions connected with motor functions. reported that some patients showed symptoms like motor or sensitive deficit and/or movement disorder. In addition, aggravation of specific motor functions has been reported for Parkinsonian patients. The “reward” group from our results supports the relation between some Parkinsonian symptoms, such as impulse control disorder and reward, especially monetary reward. Another group is represented by eight functions and concerns physical and mental suffering. Pain is established as an important symptom of COVID-19, both in the acute phase of the disease and at later stages. Potential mechanisms change nociceptor excitability, which are likely to develop pain, induce neuropathies, and worsen existing pain states. Moreover, painful symptoms, as well as muscular, joint, chronic, and neuropathic pain, are clear clinical manifestations of COVID-19 infection. For the next group, 14 functions related to the lucidity filling have been grouped. The dysexecutive syndrome, with attention and orientation disorders, has been documented as a consequence of COVID-19. This syndrome is directly related to the listed functions “proprioceptive information,” “visuospatial task,” “alertness,” and “executive control.” reported an increased rate of delirium and neurological alteration in COVID-19 patients. Other studies described neurological manifestations, such as dizziness, altered consciousness, disorientation, and delirium. The fifth group consists of 16 functions associated with emotional intensity and modulation. Literature reviews on coronaviruses (CoVs) reported that during acute illness, patients are suffering from depressed mood, anxiety disorders, psychosis, and irritability. Finally, cinq functions concerning sensory inputs like visual, auditory, and odor tasks have been found in our results, which are compatible with some reported SARS-CoV-2 symptoms.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>35767</offset><text>Thanks to its topographical distance correlation, the LinkRbrain platform listed the genes co-expressed with ACE2 that could be affected by SARS-CoV-2 infection. One cluster concerns olfactory receptors, but there are also genes in relation to cognitive functions like executive functions and neurodegenerative diseases like Alzheimer’s, Parkinson’s, and dementia. We identified eight genes coding for ORs, such as OR10H1, OR52B6, and OR8S1. Studies demonstrated that in the case of humans and mice (transgenic), the brain was a target organ for infection in SARS-CoV-2. Besides, these studies show that the virus could reach the brain by the olfactory bulb or by the olfactory tract of the CNS. Furthermore, demonstrated that ORs facilitate the transport of the virus using the vagal nerve in the context of COVID-19. showed that in mice infected intranasally with neurovirulent strains of HCoV-OC43, virus enters the CNS via the olfactory nerves with subsequent transneuronal retrograde dissemination. Once the brain is infected by SARS-CoV-2, several neurological effects are reported. It has been shown that other CoVs like human HCoV-OC43 or SARS-CoV were associated with neuronal complications, such as inflammation and encephalomyelitis. Groups that could be related to these neurological symptoms emerged in our results, such as inflammation, myelination, immunity, ischemia, and cancer genes. Nonetheless, demonstrated that murine coronavirus can cause direct lysis of oligodendrocytes and final demyelination in the human CNS. computed tomography and MRI reports of hemorrhagic necrotising encephalopathy of a COVID-19 female. Other studies described several symptoms of inflammatory-induced nerve dysfunctions. Furthermore, reported that several COVID-19 patients developed the autoimmune Guillain–Barré syndrome after a few days following the onset of SARS-CoV-2 infection. The other well-distinguished cluster is composed of genes related to neurodegenerative diseases, such as Alzheimer’s and Parkinson’s diseases. This group could be explained with the presence of genes related to demyelination and inflammation. In the literature, especially on transgenic mice, a direct causal relationship has been reported between HCoV-OC43, MHV, certain neuropathogenesis, and degeneration of specific cognitive functions. In addition, reported that the genetic material of CoVs is co-localised with Aβ protein in the brain. It is likely that SARS-CoV-2 can induce the accumulation of Aβ protein and may lead to a close relationship between Alzheimer’s disease susceptibility and neuroinflammation due to SARS-CoV-2. Alzheimer’s disease does not appear to be the only one worsening neuroinflammation and decreasing cognitive function. According to our results and the literature, the hypothetical vulnerability of SARS-CoV-2 localised in basal ganglia and dopaminergic brain regions might increase Parkinsonian symptoms. This could be induced by a systemic failure of the dopamine synthesis pathway. It has been established that alterations in apoptosis-related signalling pathways are involved in Alzheimer’s and Parkinson’s diseases. In our results, we found several genes related to cancer. In the literature, some of these genes, such as RBMY1A3P and TP53, are involved in apoptosis. Therefore, modulation of neuronal apoptosis by SARS-CoV-2 during latent infections could possibly be related to alterations in neuronal processes, leading to neuronal degeneration and brain damage. Furthermore, other diseases seem to be correlated with SARS-CoV-2 like dementia. released a meta-analysis on symptoms presented over 236,379 survivors of COVID-19 6 months after their contamination. It was noticed that dementia, anxiety disorder, and psychotic disorder are substantial psychiatric morbidity related to COVID-19 infection. Finally, studies found that other senses are perturbed: vision, hearing, and equilibrium. In our results, we found several genes related to these symptoms like AIPL1 and TMC2. Moreover, conjunctivitis has been a documented phenomenon in COVID-19, and reverse transcription polymerase chain reaction of conjunctiva and tears has tested positive for SARS-CoV-2.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>39977</offset><text>To compare our results with other brain data, we analysed the GSE164332 data that had focused on the frontal cortex. Intersection of a larger set of our results for ACE2/TMPRSS2 (Supplementary Table 4) with that of) provided us with five genes, namely, SLC14A1, HIF3A, RGS5, ZNF622 (instead of ZNF621), and HBA2. The HIF3A, RGS5, and HBA2 genes were validated by quantitative PCR (qPCR) method. In addition,) considered that these genes are the most deregulated (mRNA encoding the HBA hemoglobin subunits upregulated, and the SLC14A1, HIF3A, and RGS5 genes downregulated), and they are associated with hypoxia and inflammation.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>40605</offset><text>Also, we found four common deregulated genes (INP5D, PRKCA, LRP1, and FCGR2A) in another study focused on the following brain regions: the dorsolateral prefrontal cortex, the medulla oblongata, and the choroid plexus GSE164485. We also found other representatives of the same family for others genes. For example, we obtained CD81 and CD82 instead of CD83. Similarly, we obtained DOCK1, an important paralog of DOCK2.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>41023</offset><text>We were also interested in the pathways where our gene results are involved. Based on the exploration of GeneCard, the pathways that we found are implicated in the transport of glucose, glycosylation, innate immune system, GPCR, and also apoptosis, immune response IFN, interferon, and others. These results are confirmed with those obtained from the peripheral blood of convalescent people.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>41415</offset><text>Furthermore, from our results, several genes appear as correlated to this infection as other works based on exploration of data from patient infected by SARS-CoV-2. From these genes, we note the following: CXCR6), CST9L4 (, NOXO1, IL28B, FGF23, and finally, the controverted vitamin D receptor VDR.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>41714</offset><text>In this work, we attempted to relate the information processing performed with the cognitive and sensorimotor functions, and the genes revealed by their mRNA expression level. This type of methodology is used by who concluded to a relation between the cognitive function and the genetic expression. highlighted the executive functioning impairment, underlining the role of inflammatory processes. They reported a positive association between attentional deficits and inflammatory levels. In our results, both genetic and functional results are consistent. The altered functions on the movement and reward reflect the connection of certain genes with Parkinson’s disease. The functions related to memory and lucidity are directly correlated with inflammation, immunity, and neurodegenerative diseases, such as Alzheimer’s and dementia. Finally, it appears that sensory inputs are impacted, such as visual, auditory, and odor tasks. In our results, we found olfactory receptors and genes related to vision, hearing, and equilibrium disturbances.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>42762</offset><text>Limitations</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>42774</offset><text>Even though our results are coherent with observed COVID-19 neurological manifestations, and that some results are validated with infected people, the limit of this method remains in the nature of the cognitive and sensorimotor database and the lack of similar genetic data that cover the whole brain, from infected participant. The cognitive and sensorimotor database is composed with coordinates extracted from the literature. In order to complete this work, it would be necessary to conduct real experiments based on these results as they are not definitive and can only be used as a substantial field of research. This method could generate new hypotheses to explore the neurological manifestations of COVID-19. It presents results in an objective and global manner, based on existing knowledge produced by the scientific community. The technical and methodological contributions of LinkRbrain enable a functional and transcriptome characterisation of certain pathologies, including COVID-19. The creation of large open-source databases is part of the current big data scientific revolution. These techniques produce an intelligible synthesis of results and provide access to cutting-edge knowledge from related fields, which are often fundamental to successful research.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>44050</offset><text>Data Availability Statement</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>44078</offset><text>The original contributions presented in this study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title_1</infon><offset>44244</offset><text>Author Contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>44265</offset><text>SM conceived and designed the experiments. SM, MR, and CL performed the experiments and analysed the data. All authors wrote the manuscript, contributed to the article, and approved the submitted version.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title_1</infon><offset>44470</offset><text>Conflict of Interest</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>44491</offset><text>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title_1</infon><offset>44664</offset><text>Publisher’s Note</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>44683</offset><text>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">title_1</infon><offset>45030</offset><text>Funding</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">paragraph</infon><offset>45038</offset><text>This study was funded by the French General Secretariat for Investment via the National Research Agency (ANR) “Programme d’Investissement d’Avenir (PIA ANR-10-EQPX-0021-01)” and by the CNRS innovation (Prematuration Programme). This study was realised in the framework of the “équipement d’excellence MATRICE” (matricememory.fr). This program was administratively sponsored by the HESAM University.</text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">footnote</infon><offset>45452</offset><text> https://www.linkrbrain.org </text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">footnote</infon><offset>45481</offset><text> http://neurosynth.org </text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">footnote</infon><offset>45505</offset><text> ncbi.nlm.nih.gov/geo/ </text></passage><passage><infon key="section_type">ACK_FUND</infon><infon key="type">footnote</infon><offset>45529</offset><text> https://pubchem.ncbi.nlm.nih.gov/pathway/WikiPathways:WP4846 </text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>45592</offset><text>Supplementary Material</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>45615</offset><text>The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnint.2022.756604/full#supplementary-material</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>45774</offset><text>References</text></passage><passage><infon key="issue">e0246590</infon><infon key="name_0">surname:Alemanno;given-names:F.</infon><infon key="name_1">surname:Houdayer;given-names:E.</infon><infon key="name_2">surname:Parma;given-names:A.</infon><infon key="name_3">surname:Spina;given-names:A.</infon><infon key="name_4">surname:Del Forno;given-names:A.</infon><infon key="name_5">surname:Scatolini;given-names:A.</infon><infon key="pub-id_doi">10.1371/journal.pone.0246590</infon><infon key="pub-id_pmid">33556127</infon><infon key="section_type">REF</infon><infon key="source">PLoS One</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2021</infon><offset>45785</offset><text>COVID-19 cognitive deficits after respiratory assistance in the subacute phase: a COVID-rehabilitation unit experience.</text></passage><passage><infon key="issue">100163</infon><infon key="name_0">surname:Almeria;given-names:M.</infon><infon key="name_1">surname:Cejudo;given-names:J. C.</infon><infon key="name_2">surname:Sotoca;given-names:J.</infon><infon key="name_3">surname:Deus;given-names:J.</infon><infon key="name_4">surname:Krupinski;given-names:J.</infon><infon key="pub-id_doi">10.1016/j.bbih.2020.100163</infon><infon key="pub-id_pmid">33111132</infon><infon key="section_type">REF</infon><infon key="source">Brain Behav. Immun. Health</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2020</infon><offset>45905</offset><text>Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment.</text></passage><passage><infon key="fpage">403</infon><infon key="lpage">412</infon><infon key="name_0">surname:Alothaid;given-names:H.</infon><infon key="name_1">surname:Aldughaim;given-names:M. S. K.</infon><infon key="name_2">surname:El Bakkouri;given-names:K.</infon><infon key="name_3">surname:AlMashhadi;given-names:S.</infon><infon key="name_4">surname:Al-Qahtani;given-names:A. A.</infon><infon key="pub-id_doi">10.1080/19336950.2020.1837439</infon><infon key="pub-id_pmid">33092458</infon><infon key="section_type">REF</infon><infon key="source">Channels</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2020</infon><offset>46015</offset><text>Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment.</text></passage><passage><infon key="fpage">8913</infon><infon key="lpage">8921</infon><infon key="name_0">surname:Arbour;given-names:N.</infon><infon key="name_1">surname:Day;given-names:R.</infon><infon key="name_2">surname:Newcombe;given-names:J.</infon><infon key="name_3">surname:Talbot;given-names:P. J.</infon><infon key="pub-id_doi">10.1128/jvi.74.19.8913-8921.2000</infon><infon key="pub-id_pmid">10982334</infon><infon key="section_type">REF</infon><infon key="source">J. Virol.</infon><infon key="type">ref</infon><infon key="volume">74</infon><infon key="year">2000</infon><offset>46213</offset><text>Neuroinvasion by human respiratory coronaviruses.</text></passage><passage><infon key="fpage">995</infon><infon key="lpage">998</infon><infon key="name_0">surname:Baig;given-names:A. M.</infon><infon key="name_1">surname:Khaleeq;given-names:A.</infon><infon key="name_2">surname:Ali;given-names:U.</infon><infon key="name_3">surname:Syeda;given-names:H.</infon><infon key="pub-id_doi">10.1021/acschemneuro.0c00122</infon><infon key="pub-id_pmid">32167747</infon><infon key="section_type">REF</infon><infon key="source">ACS Chem Neurosci.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2020</infon><offset>46263</offset><text>Evidence of the COVID-19 Virus Targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms.</text></passage><passage><infon key="fpage">682</infon><infon key="lpage">683</infon><infon key="name_0">surname:Boldrini;given-names:M.</infon><infon key="name_1">surname:Canoll;given-names:P. D.</infon><infon key="name_2">surname:Klein;given-names:R. S.</infon><infon key="pub-id_doi">10.1001/jamapsychiatry.2021.0500</infon><infon key="pub-id_pmid">33769431</infon><infon key="section_type">REF</infon><infon key="source">JAMA Psychiatry</infon><infon key="type">ref</infon><infon key="volume">78</infon><infon key="year">2021</infon><offset>46395</offset><text>How COVID-19 affects the brain.</text></passage><passage><infon key="fpage">410</infon><infon key="lpage">421</infon><infon key="name_0">surname:Butler;given-names:N.</infon><infon key="name_1">surname:Pewe;given-names:L.</infon><infon key="name_2">surname:Trandem;given-names:K.</infon><infon key="name_3">surname:Perlman;given-names:S.</infon><infon key="pub-id_doi">10.1016/j.virol.2005.11.044</infon><infon key="pub-id_pmid">16413043</infon><infon key="section_type">REF</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">347</infon><infon key="year">2006</infon><offset>46427</offset><text>Murine encephalitis caused by HCoV-OC43, a human coronavirus with broad species specificity, is partly immune-mediated.</text></passage><passage><infon key="issue">670879</infon><infon key="name_0">surname:Ceolin;given-names:G.</infon><infon key="name_1">surname:Mano;given-names:G. P. R.</infon><infon key="name_2">surname:Hames;given-names:N. S.</infon><infon key="name_3">surname:Antunes;given-names:L. D. C.</infon><infon key="name_4">surname:Brietzke;given-names:E.</infon><infon key="name_5">surname:Rieger;given-names:D. K.</infon><infon key="pub-id_doi">10.3389/fnins.2021.670879</infon><infon key="pub-id_pmid">34054418</infon><infon key="section_type">REF</infon><infon key="source">Front. Neurosci.</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2021</infon><offset>46547</offset><text>Vitamin D, depressive symptoms, and Covid-19 Pandemic.</text></passage><passage><infon key="fpage">748</infon><infon key="lpage">751</infon><infon key="name_0">surname:Chen;given-names:L.</infon><infon key="name_1">surname:Liu;given-names:M.</infon><infon key="name_2">surname:Zhang;given-names:Z.</infon><infon key="name_3">surname:Qiao;given-names:K.</infon><infon key="name_4">surname:Huang;given-names:T.</infon><infon key="name_5">surname:Chen;given-names:M.</infon><infon key="pub-id_doi">10.1136/bjophthalmol-2020-316304</infon><infon key="pub-id_pmid">32265202</infon><infon key="section_type">REF</infon><infon key="source">Br. J. Ophthalmol.</infon><infon key="type">ref</infon><infon key="volume">104</infon><infon key="year">2020</infon><offset>46602</offset><text>Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease.</text></passage><passage><infon key="issue">573095</infon><infon key="name_0">surname:Chen;given-names:R.</infon><infon key="name_1">surname:Wang;given-names:K.</infon><infon key="name_2">surname:Yu;given-names:J.</infon><infon key="name_3">surname:French;given-names:L.</infon><infon key="name_4">surname:Chen;given-names:Z.</infon><infon key="name_5">surname:Wen;given-names:C.</infon><infon key="pub-id_doi">10.3389/fneur.2020.573095</infon><infon key="pub-id_pmid">33551947</infon><infon key="section_type">REF</infon><infon key="source">Front. Neurol.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2021</infon><offset>46697</offset><text>The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains.</text></passage><passage><infon key="comment">Preprint</infon><infon key="name_0">surname:Chen;given-names:S.</infon><infon key="name_1">surname:Han;given-names:Y.</infon><infon key="name_2">surname:Yang;given-names:L.</infon><infon key="name_3">surname:Kim;given-names:T.</infon><infon key="name_4">surname:Nair;given-names:M.</infon><infon key="name_5">surname:Harschnitz;given-names:O.</infon><infon key="pub-id_doi">10.21203/rs.3.rs-513461/v1</infon><infon key="pub-id_pmid">34031650</infon><infon key="section_type">REF</infon><infon key="source">Res. Sq.</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>46795</offset><text>SARS-CoV-2 infection causes dopaminergic neuron senescence.</text></passage><passage><infon key="issue">e115913</infon><infon key="name_0">surname:Cioli;given-names:C.</infon><infon key="name_1">surname:Abdi;given-names:H.</infon><infon key="name_2">surname:Beaton;given-names:D.</infon><infon key="name_3">surname:Burnod;given-names:Y.</infon><infon key="name_4">surname:Mesmoudi;given-names:S.</infon><infon key="pub-id_doi">10.1371/journal.pone.0115913</infon><infon key="pub-id_pmid">25546015</infon><infon key="section_type">REF</infon><infon key="source">PLoS One</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2014</infon><offset>46855</offset><text>Differences in human cortical gene expression match the temporal properties of large-scale functional networks.</text></passage><passage><infon key="fpage">2502</infon><infon key="lpage">2518</infon><infon key="name_0">surname:Drew;given-names:D. S.</infon><infon key="name_1">surname:Muhammed;given-names:K.</infon><infon key="name_2">surname:Baig;given-names:F.</infon><infon key="pub-id_doi">10.1093/brain/awaa198</infon><infon key="pub-id_pmid">32761061</infon><infon key="section_type">REF</infon><infon key="source">Brain</infon><infon key="type">ref</infon><infon key="volume">143</infon><infon key="year">2020</infon><offset>46967</offset><text>Dopamine and reward hypersensitivity in Parkinson’s disease with impulse control disorder.</text></passage><passage><infon key="fpage">1813</infon><infon key="lpage">1817</infon><infon key="name_0">surname:Evan;given-names:A.</infon><infon key="name_1">surname:Collins;given-names:D.</infon><infon key="name_2">surname:Mills;given-names:S.</infon><infon key="name_3">surname:Brown;given-names:D.</infon><infon key="name_4">surname:Kelly;given-names:R.</infon><infon key="name_5">surname:Peters;given-names:T.</infon><infon key="pub-id_doi">10.1109/NSSMIC.1993.373602</infon><infon key="section_type">REF</infon><infon key="source">Proceedings of the 1993 Nuclear Science Symposium and Medical Imaging Conference</infon><infon key="type">ref</infon><infon key="year">1993</infon><offset>47060</offset><text>3D statistical neuroanatomical models from 305 MRI Volumes</text></passage><passage><infon key="issue">5809</infon><infon key="name_0">surname:Ferren;given-names:M.</infon><infon key="name_1">surname:Favède;given-names:V.</infon><infon key="name_2">surname:Decimo;given-names:D.</infon><infon key="name_3">surname:Iampietro;given-names:M.</infon><infon key="name_4">surname:Lieberman;given-names:N. A. P.</infon><infon key="name_5">surname:Weickert;given-names:J. L.</infon><infon key="pub-id_doi">10.1038/s41467-021-26096-z</infon><infon key="pub-id_pmid">34608167</infon><infon key="section_type">REF</infon><infon key="source">Nat. Commun.</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2021</infon><offset>47119</offset><text>Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection.</text></passage><passage><infon key="issue">101839</infon><infon key="name_0">surname:Fodoulian;given-names:L.</infon><infon key="name_1">surname:Tuberosa;given-names:J.</infon><infon key="name_2">surname:Rossier;given-names:D.</infon><infon key="name_3">surname:Boillat;given-names:M.</infon><infon key="name_4">surname:Kan;given-names:C.</infon><infon key="name_5">surname:Pauli;given-names:V.</infon><infon key="pub-id_doi">10.1016/j.isci.2020.101839</infon><infon key="pub-id_pmid">33251489</infon><infon key="section_type">REF</infon><infon key="source">iScience</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2020</infon><offset>47192</offset><text>SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain.</text></passage><passage><infon key="fpage">115</infon><infon key="lpage">130</infon><infon key="name_0">surname:Frantzi;given-names:K.</infon><infon key="name_1">surname:Ananiadou;given-names:S.</infon><infon key="pub-id_doi">10.1007/3-540-49653-X_35</infon><infon key="section_type">REF</infon><infon key="source">Int. J. Digit. Libr.</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2000</infon><offset>47293</offset><text>Automatic recognition of multi-word terms: the c-value/nc-value method.</text></passage><passage><infon key="fpage">1129</infon><infon key="lpage">1164</infon><infon key="name_0">surname:Fruchterman;given-names:T. M. J.</infon><infon key="name_1">surname:Reingold;given-names:E.</infon><infon key="pub-id_doi">10.1002/spe.4380211102</infon><infon key="section_type">REF</infon><infon key="source">Softw. Pract. Exp.</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">1991</infon><offset>47365</offset><text>Graph drawing by force-directed placement.</text></passage><passage><infon key="issue">118</infon><infon key="name_0">surname:Fullard;given-names:J. F.</infon><infon key="name_1">surname:Lee;given-names:H. C.</infon><infon key="name_2">surname:Voloudakis;given-names:G.</infon><infon key="name_3">surname:Suo;given-names:S.</infon><infon key="name_4">surname:Javidfar;given-names:B.</infon><infon key="name_5">surname:Shao;given-names:Z.</infon><infon key="pub-id_doi">10.1186/s13073-021-00933-8</infon><infon key="pub-id_pmid">34281603</infon><infon key="section_type">REF</infon><infon key="source">Genome Med.</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2021</infon><offset>47408</offset><text>Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19.</text></passage><passage><infon key="fpage">13</infon><infon key="lpage">21</infon><infon key="name_0">surname:Gagliardi;given-names:S.</infon><infon key="name_1">surname:Poloni;given-names:E. T.</infon><infon key="name_2">surname:Pandini;given-names:C.</infon><infon key="name_3">surname:Garofalo;given-names:M.</infon><infon key="name_4">surname:Dragoni;given-names:F.</infon><infon key="name_5">surname:Medici;given-names:V.</infon><infon key="pub-id_doi">10.1016/j.bbi.2021.05.012</infon><infon key="pub-id_pmid">34022369</infon><infon key="section_type">REF</infon><infon key="source">Brain Behav. Immun.</infon><infon key="type">ref</infon><infon key="volume">97</infon><infon key="year">2021</infon><offset>47511</offset><text>Detection of SARS-CoV-2 genome and whole transcriptome sequencing in frontal cortex of COVID-19 patients.</text></passage><passage><infon key="issue">8570</infon><infon key="name_0">surname:George;given-names:B.</infon><infon key="name_1">surname:Amjesh;given-names:R.</infon><infon key="name_2">surname:Paul;given-names:A. M.</infon><infon key="name_3">surname:Santhoshkumar;given-names:T. R.</infon><infon key="name_4">surname:Pillai;given-names:M. R.</infon><infon key="name_5">surname:Kumar;given-names:R.</infon><infon key="pub-id_doi">10.1038/s41598-021-87703-z</infon><infon key="pub-id_pmid">33883570</infon><infon key="section_type">REF</infon><infon key="source">Sci. Rep.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2021</infon><offset>47617</offset><text>Evidence of a dysregulated vitamin D endocrine system in SARS-CoV-2 infected patient’s lung cells.</text></passage><passage><infon key="fpage">107</infon><infon key="lpage">110</infon><infon key="name_0">surname:Harmer;given-names:D.</infon><infon key="name_1">surname:Gilbert;given-names:M.</infon><infon key="name_2">surname:Borman;given-names:R.</infon><infon key="name_3">surname:Clark;given-names:K. L.</infon><infon key="pub-id_doi">10.1016/s0014-5793(02)03640-2</infon><infon key="pub-id_pmid">12459472</infon><infon key="section_type">REF</infon><infon key="source">FEBS Lett.</infon><infon key="type">ref</infon><infon key="volume">532</infon><infon key="year">2002</infon><offset>47718</offset><text>Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme.</text></passage><passage><infon key="fpage">391</infon><infon key="lpage">399</infon><infon key="name_0">surname:Hawrylycz;given-names:M. J.</infon><infon key="name_1">surname:Lein;given-names:E. S.</infon><infon key="name_2">surname:Guillozet-Bongaarts;given-names:A. L.</infon><infon key="name_3">surname:Shen;given-names:E. H.</infon><infon key="name_4">surname:Ng;given-names:L.</infon><infon key="name_5">surname:Miller;given-names:J. A.</infon><infon key="pub-id_doi">10.1038/nature11405</infon><infon key="pub-id_pmid">22996553</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">489</infon><infon key="year">2012</infon><offset>47819</offset><text>An anatomically comprehensive atlas of the adult human brain transcriptome.</text></passage><passage><infon key="fpage">2268</infon><infon key="lpage">2270</infon><infon key="name_0">surname:Helms;given-names:J.</infon><infon key="name_1">surname:Kremer;given-names:S.</infon><infon key="name_2">surname:Merdji;given-names:H.</infon><infon key="name_3">surname:Clere-Jehl;given-names:R.</infon><infon key="name_4">surname:Schenck;given-names:M.</infon><infon key="name_5">surname:Kummerlen;given-names:C.</infon><infon key="pub-id_doi">10.1056/NEJMc2008597</infon><infon key="pub-id_pmid">32294339</infon><infon key="section_type">REF</infon><infon key="source">N. Engl. J. Med.</infon><infon key="type">ref</infon><infon key="volume">382</infon><infon key="year">2020</infon><offset>47895</offset><text>Neurologic Features in Severe SARS-CoV-2 Infection.</text></passage><passage><infon key="issue">113837</infon><infon key="name_0">surname:Hernández;given-names:V. S.</infon><infon key="name_1">surname:Zetter;given-names:M. A.</infon><infon key="name_2">surname:Guerra;given-names:E. C.</infon><infon key="name_3">surname:Hernández-Araiza;given-names:I.</infon><infon key="name_4">surname:Karuzin;given-names:N.</infon><infon key="name_5">surname:Hernández-Pérez;given-names:O. R.</infon><infon key="pub-id_doi">10.1016/j.expneurol.2021.113837</infon><infon key="pub-id_pmid">34400158</infon><infon key="section_type">REF</infon><infon key="source">Exp. Neurol.</infon><infon key="type">ref</infon><infon key="volume">345</infon><infon key="year">2021</infon><offset>47947</offset><text>ACE2 expression in rat brain: implications for COVID-19 associated neurological manifestations.</text></passage><passage><infon key="fpage">271</infon><infon key="lpage">280.e8</infon><infon key="name_0">surname:Hoffmann;given-names:M.</infon><infon key="name_1">surname:Kleine-Weber;given-names:H.</infon><infon key="name_2">surname:Schroeder;given-names:S.</infon><infon key="name_3">surname:Krüger;given-names:N.</infon><infon key="name_4">surname:Herrler;given-names:T.</infon><infon key="name_5">surname:Erichsen;given-names:S.</infon><infon key="pub-id_pmid">32142651</infon><infon key="section_type">REF</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">181</infon><infon key="year">2020</infon><offset>48043</offset><text>SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.</text></passage><passage><infon key="fpage">821</infon><infon key="lpage">828</infon><infon key="name_0">surname:Jones;given-names:A. R.</infon><infon key="name_1">surname:Overly;given-names:C. C.</infon><infon key="name_2">surname:Sunkin;given-names:S. M.</infon><infon key="pub-id_doi">10.1038/nrn2722</infon><infon key="pub-id_pmid">19826436</infon><infon key="section_type">REF</infon><infon key="source">Nat. Rev. Neurosci.</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2009</infon><offset>48151</offset><text>The Allen Brain Atlas: 5 years and beyond.</text></passage><passage><infon key="fpage">259</infon><infon key="lpage">289</infon><infon key="name_0">surname:Kageura;given-names:K.</infon><infon key="pub-id_doi">10.1075/term.3.2.03kag</infon><infon key="pub-id_pmid">33486653</infon><infon key="section_type">REF</infon><infon key="source">Terminology</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">1996</infon><offset>48194</offset><text>Methods of automatic term recognition: a review.</text></passage><passage><infon key="issue">242</infon><infon key="name_0">surname:Kasela;given-names:S.</infon><infon key="name_1">surname:Daniloski;given-names:Z.</infon><infon key="name_2">surname:Bollepalli;given-names:S.</infon><infon key="name_3">surname:Jordan;given-names:T. X.</infon><infon key="name_4">surname:tenOever;given-names:B. R.</infon><infon key="name_5">surname:Sanjana;given-names:N. E.</infon><infon key="pub-id_doi">10.1186/s13059-021-02454-4</infon><infon key="pub-id_pmid">34425859</infon><infon key="section_type">REF</infon><infon key="source">Genome Biol.</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2021</infon><offset>48243</offset><text>Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus.</text></passage><passage><infon key="fpage">436</infon><infon key="lpage">440</infon><infon key="name_0">surname:Kemp;given-names:H. I.</infon><infon key="name_1">surname:Corner;given-names:E.</infon><infon key="name_2">surname:Colvin;given-names:L. A.</infon><infon key="pub-id_doi">10.1016/j.bja.2020.05.021</infon><infon key="pub-id_pmid">32560913</infon><infon key="section_type">REF</infon><infon key="source">Br. J. Anaesth.</infon><infon key="type">ref</infon><infon key="volume">125</infon><infon key="year">2020</infon><offset>48369</offset><text>Chronic pain after COVID-19: implications for rehabilitation.</text></passage><passage><infon key="fpage">949</infon><infon key="lpage">956</infon><infon key="name_0">surname:Kerslake;given-names:R.</infon><infon key="name_1">surname:Hall;given-names:M.</infon><infon key="name_2">surname:Randeva;given-names:H. S.</infon><infon key="name_3">surname:Spandidos;given-names:D. A.</infon><infon key="name_4">surname:Chatha;given-names:K.</infon><infon key="name_5">surname:Kyrou;given-names:I.</infon><infon key="pub-id_doi">10.3892/ijmm.2020.4646</infon><infon key="pub-id_pmid">32705281</infon><infon key="section_type">REF</infon><infon key="source">Int. J. Mol. Med.</infon><infon key="type">ref</infon><infon key="volume">46</infon><infon key="year">2020</infon><offset>48431</offset><text>Co-expression of peripheral olfactory receptors with SARS-CoV-2 infection mediators: potential implications beyond loss of smell as a COVID-19 symptom.</text></passage><passage><infon key="fpage">254</infon><infon key="lpage">269</infon><infon key="name_0">surname:Kulkarni;given-names:P. G.</infon><infon key="name_1">surname:Sakharkar;given-names:A.</infon><infon key="name_2">surname:Banerjee;given-names:T.</infon><infon key="pub-id_doi">10.1038/s41440-021-00800-4</infon><infon key="pub-id_pmid">34848886</infon><infon key="section_type">REF</infon><infon key="source">Hypertens. Res.</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2022</infon><offset>48583</offset><text>Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients.</text></passage><passage><infon key="fpage">245</infon><infon key="lpage">250</infon><infon key="name_0">surname:Lev;given-names:N.</infon><infon key="name_1">surname:Melamed;given-names:E.</infon><infon key="name_2">surname:Offen;given-names:D.</infon><infon key="pub-id_doi">10.1016/S0278-5846(03)00019-8</infon><infon key="pub-id_pmid">12657363</infon><infon key="section_type">REF</infon><infon key="source">Prog. Neuropsychopharmacol. Biol. Psychiatry</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2003</infon><offset>48667</offset><text>Apoptosis and Parkinson’s disease.</text></passage><passage><infon key="fpage">423</infon><infon key="lpage">434</infon><infon key="name_0">surname:Li;given-names:T.</infon><infon key="name_1">surname:Huang;given-names:H. Y.</infon><infon key="name_2">surname:Wang;given-names:H. D.</infon><infon key="name_3">surname:Gao;given-names:C.-C.</infon><infon key="name_4">surname:Liang;given-names:H.</infon><infon key="name_5">surname:Deng;given-names:C. L.</infon><infon key="pub-id_doi">10.1089/neu.2021.0382</infon><infon key="pub-id_pmid">34861788</infon><infon key="section_type">REF</infon><infon key="source">J. Neurotrauma</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2022</infon><offset>48704</offset><text>Restoration of brain angiotensin-converting enzyme 2 alleviates neurological deficits after severe traumatic brain injury via mitigation of pyroptosis and apoptosis.</text></passage><passage><infon key="issue">100484</infon><infon key="name_0">surname:Lu;given-names:Y.</infon><infon key="name_1">surname:Li;given-names:X.</infon><infon key="name_2">surname:Geng;given-names:D.</infon><infon key="name_3">surname:Mei;given-names:N.</infon><infon key="name_4">surname:Wu;given-names:P. Y.</infon><infon key="name_5">surname:Huang;given-names:C. C.</infon><infon key="pub-id_doi">10.1016/j.eclinm.2020.100484</infon><infon key="pub-id_pmid">32838240</infon><infon key="section_type">REF</infon><infon key="source">EClinicalMedicine</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">2020</infon><offset>48870</offset><text>Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study.</text></passage><passage><infon key="fpage">2950</infon><infon key="lpage">2958</infon><infon key="name_0">surname:Mahalingam;given-names:R.</infon><infon key="name_1">surname:Dharmalingam;given-names:P.</infon><infon key="name_2">surname:Santhanam;given-names:A.</infon><infon key="name_3">surname:Kotla;given-names:S.</infon><infon key="name_4">surname:Davuluri;given-names:G.</infon><infon key="name_5">surname:Karmouty-Quintana;given-names:H.</infon><infon key="pub-id_doi">10.1002/jcp.30054</infon><infon key="pub-id_pmid">32944935</infon><infon key="section_type">REF</infon><infon key="source">J. Cell. Physiol.</infon><infon key="type">ref</infon><infon key="volume">236</infon><infon key="year">2021</infon><offset>48965</offset><text>Single-cell RNA sequencing analysis of SARS-CoV-2 entry receptors in human organoids.</text></passage><passage><infon key="issue">e885</infon><infon key="name_0">surname:McFarland;given-names:A. J.</infon><infon key="name_1">surname:Yousuf;given-names:M. S.</infon><infon key="name_2">surname:Shiers;given-names:S.</infon><infon key="name_3">surname:Price;given-names:T. J.</infon><infon key="pub-id_doi">10.1097/PR9.0000000000000885</infon><infon key="pub-id_pmid">33458558</infon><infon key="section_type">REF</infon><infon key="source">Pain Rep.</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2021</infon><offset>49051</offset><text>Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain.</text></passage><passage><infon key="fpage">857</infon><infon key="lpage">862</infon><infon key="name_0">surname:Mcloughlin;given-names:B. C.</infon><infon key="name_1">surname:Miles;given-names:A.</infon><infon key="name_2">surname:Webb;given-names:T. E.</infon><infon key="name_3">surname:Knopp;given-names:P.</infon><infon key="name_4">surname:Eyres;given-names:C.</infon><infon key="name_5">surname:Fabbri;given-names:A.</infon><infon key="name_6">surname:Humphries;given-names:F.</infon><infon key="pub-id_doi">10.1007/s41999-020-00353-8</infon><infon key="pub-id_pmid">32666303</infon><infon key="section_type">REF</infon><infon key="source">Eur. Geriatr. Med.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2020</infon><offset>49163</offset><text>Functional and cognitive outcomes after COVID-19 delirium.</text></passage><passage><infon key="fpage">168</infon><infon key="lpage">175</infon><infon key="name_0">surname:Meinhardt;given-names:J.</infon><infon key="name_1">surname:Radke;given-names:J.</infon><infon key="name_2">surname:Dittmayer;given-names:C.</infon><infon key="name_3">surname:Franz;given-names:J.</infon><infon key="name_4">surname:Thomas;given-names:C.</infon><infon key="name_5">surname:Mothes;given-names:R.</infon><infon key="pub-id_doi">10.1038/s41593-020-00758-5</infon><infon key="pub-id_pmid">33257876</infon><infon key="section_type">REF</infon><infon key="source">Nat. Neurosci.</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2021</infon><offset>49222</offset><text>Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19.</text></passage><passage><infon key="fpage">458</infon><infon key="lpage">466</infon><infon key="name_0">surname:Meppiel;given-names:E.</infon><infon key="name_1">surname:Peiffer-Smadja;given-names:N.</infon><infon key="name_2">surname:Maury;given-names:A.</infon><infon key="name_3">surname:Bekri;given-names:I.</infon><infon key="name_4">surname:Delorme;given-names:C.</infon><infon key="name_5">surname:Desestret;given-names:V.</infon><infon key="pub-id_doi">10.1016/j.cmi.2020.11.005</infon><infon key="pub-id_pmid">33189873</infon><infon key="section_type">REF</infon><infon key="source">Clin. Microbiol. Infect.</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2021</infon><offset>49337</offset><text>Neurologic manifestations associated with COVID-19: a multicentre registry.</text></passage><passage><infon key="fpage">44</infon><infon key="lpage">52</infon><infon key="name_0">surname:Mesmoudi;given-names:S.</infon><infon key="name_1">surname:Rodic;given-names:M.</infon><infon key="name_2">surname:Cioli;given-names:C.</infon><infon key="name_3">surname:Cointet;given-names:J. P.</infon><infon key="name_4">surname:Yarkoni;given-names:T.</infon><infon key="name_5">surname:Burnod;given-names:Y.</infon><infon key="pub-id_doi">10.1016/j.jneumeth.2014.12.008</infon><infon key="pub-id_pmid">25528112</infon><infon key="section_type">REF</infon><infon key="source">J. Neurosci. Methods</infon><infon key="type">ref</infon><infon key="volume">241</infon><infon key="year">2015</infon><offset>49413</offset><text>LinkRbrain: multi-scale data integrator of the brain.</text></passage><passage><infon key="fpage">274</infon><infon key="lpage">284</infon><infon key="name_0">surname:Murray;given-names:R. S.</infon><infon key="name_1">surname:Cai;given-names:G. Y.</infon><infon key="name_2">surname:Hoel;given-names:K.</infon><infon key="name_3">surname:Zhang;given-names:J. Y.</infon><infon key="name_4">surname:Soike;given-names:K. F.</infon><infon key="name_5">surname:Cabirac;given-names:G. F.</infon><infon key="pub-id_doi">10.1016/0042-6822(92)90757-g</infon><infon key="pub-id_pmid">1314455</infon><infon key="section_type">REF</infon><infon key="source">Virology</infon><infon key="type">ref</infon><infon key="volume">188</infon><infon key="year">1992</infon><offset>49467</offset><text>Coronavirus infects and causes demyelination in primate central nervous system.</text></passage><passage><infon key="fpage">7264</infon><infon key="lpage">7275</infon><infon key="name_0">surname:Netland;given-names:J.</infon><infon key="name_1">surname:Meyerholz;given-names:D. K.</infon><infon key="name_2">surname:Moore;given-names:S.</infon><infon key="name_3">surname:Cassell;given-names:M.</infon><infon key="name_4">surname:Perlman;given-names:S.</infon><infon key="pub-id_doi">10.1128/JVI.00737-08</infon><infon key="pub-id_pmid">18495771</infon><infon key="section_type">REF</infon><infon key="source">J. Virol.</infon><infon key="type">ref</infon><infon key="volume">82</infon><infon key="year">2008</infon><offset>49547</offset><text>Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2.</text></passage><passage><infon key="fpage">2301</infon><infon key="lpage">2312</infon><infon key="name_0">surname:Obulesu;given-names:M.</infon><infon key="name_1">surname:Lakshmi;given-names:M. J.</infon><infon key="pub-id_doi">10.1007/s11064-014-1454-4</infon><infon key="pub-id_pmid">25322820</infon><infon key="section_type">REF</infon><infon key="source">Neurochem. Res.</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2014</infon><offset>49691</offset><text>Apoptosis in Alzheimer’s disease: an understanding of the physiology, pathology and therapeutic avenues.</text></passage><passage><infon key="fpage">e01969</infon><infon key="lpage">21</infon><infon key="name_0">surname:Olivarria;given-names:G. M.</infon><infon key="name_1">surname:Cheng;given-names:Y.</infon><infon key="name_2">surname:Furman;given-names:S.</infon><infon key="name_3">surname:Pachow;given-names:C.</infon><infon key="name_4">surname:Hohsfield;given-names:L. A.</infon><infon key="name_5">surname:Smith-Geater;given-names:C.</infon><infon key="pub-id_doi">10.1128/jvi.01969-21</infon><infon key="pub-id_pmid">34935438</infon><infon key="section_type">REF</infon><infon key="source">J. Virol.</infon><infon key="type">ref</infon><infon key="volume">96</infon><infon key="year">2022</infon><offset>49798</offset><text>Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-Human ACE2 Transgenic Mice.</text></passage><passage><infon key="fpage">154</infon><infon key="lpage">159</infon><infon key="name_0">surname:Özdağ Acarli;given-names:A. N.</infon><infon key="name_1">surname:Samanci;given-names:B.</infon><infon key="name_2">surname:Ekizoğlu;given-names:E.</infon><infon key="name_3">surname:Çakar;given-names:A.</infon><infon key="name_4">surname:Şirin;given-names:N. G.</infon><infon key="name_5">surname:Gündüz;given-names:T.</infon><infon key="pub-id_doi">10.29399/npa.26148</infon><infon key="pub-id_pmid">32550783</infon><infon key="section_type">REF</infon><infon key="source">Noro Psikiyatr. Ars.</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="year">2020</infon><offset>49932</offset><text>Coronavirus Disease 2019 (COVID-19) from the point of view of neurologists: observation of neurological findings and symptoms during the combat against a pandemic.</text></passage><passage><infon key="fpage">699</infon><infon key="lpage">702</infon><infon key="name_0">surname:Paniz-Mondolfi;given-names:A.</infon><infon key="name_1">surname:Bryce;given-names:C.</infon><infon key="name_2">surname:Grimes;given-names:Z.</infon><infon key="name_3">surname:Gordon;given-names:R. E.</infon><infon key="name_4">surname:Reidy;given-names:J.</infon><infon key="name_5">surname:Lednicky;given-names:J.</infon><infon key="pub-id_doi">10.1002/jmv.25915</infon><infon key="pub-id_pmid">32314810</infon><infon key="section_type">REF</infon><infon key="source">J. Med. Virol.</infon><infon key="type">ref</infon><infon key="volume">92</infon><infon key="year">2020</infon><offset>50096</offset><text>Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).</text></passage><passage><infon key="fpage">1127</infon><infon key="lpage">1142</infon><infon key="name_0">surname:Panoskaltsis;given-names:N.</infon><infon key="name_1">surname:McCarthy;given-names:N. E.</infon><infon key="name_2">surname:Stagg;given-names:A. J.</infon><infon key="name_3">surname:Mummery;given-names:C. J.</infon><infon key="name_4">surname:Husni;given-names:M.</infon><infon key="name_5">surname:Arebi;given-names:N.</infon><infon key="pub-id_doi">10.1007/s00262-020-02725-2</infon><infon key="pub-id_pmid">33033851</infon><infon key="section_type">REF</infon><infon key="source">Cancer Immunol. Immunother.</infon><infon key="type">ref</infon><infon key="volume">70</infon><infon key="year">2021</infon><offset>50196</offset><text>Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm.</text></passage><passage><infon key="fpage">2250</infon><infon key="lpage">3153</infon><infon key="name_0">surname:Patatian;given-names:A.</infon><infon key="name_1">surname:Benech;given-names:P.</infon><infon key="pub-id_doi">10.29322/IJSRP.10.09.2020.p10560</infon><infon key="section_type">REF</infon><infon key="source">Int. J. Sci. Res. Publ.</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2020</infon><offset>50303</offset><text>Identifying potential clues on Covid-19 through coronavirus-related literature using a data-driven approach with the help of a text mining-based software, Predictsearch.</text></passage><passage><infon key="fpage">59</infon><infon key="lpage">63</infon><infon key="name_0">surname:Poldrack;given-names:R. A.</infon><infon key="pub-id_doi">10.1016/j.tics.2005.12.004</infon><infon key="pub-id_pmid">16406760</infon><infon key="section_type">REF</infon><infon key="source">Trends Cogn. Sci.</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2006</infon><offset>50473</offset><text>Can cognitive processes be inferred from neuroimaging data?</text></passage><passage><infon key="fpage">E119</infon><infon key="lpage">E120</infon><infon key="name_0">surname:Poyiadji;given-names:N.</infon><infon key="name_1">surname:Shahin;given-names:G.</infon><infon key="name_2">surname:Noujaim;given-names:D.</infon><infon key="name_3">surname:Stone;given-names:M.</infon><infon key="name_4">surname:Patel;given-names:S.</infon><infon key="name_5">surname:Griffith;given-names:B.</infon><infon key="pub-id_doi">10.1148/radiol.2020201187</infon><infon key="pub-id_pmid">32228363</infon><infon key="section_type">REF</infon><infon key="source">Radiology</infon><infon key="type">ref</infon><infon key="volume">296</infon><infon key="year">2020</infon><offset>50533</offset><text>COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features.</text></passage><passage><infon key="issue">1446</infon><infon key="name_0">surname:Ragab;given-names:D.</infon><infon key="name_1">surname:Salah Eldin;given-names:H.</infon><infon key="name_2">surname:Taeimah;given-names:M.</infon><infon key="name_3">surname:Khattab;given-names:R.</infon><infon key="name_4">surname:Salem;given-names:R.</infon><infon key="pub-id_doi">10.3389/fimmu.2020.01446</infon><infon key="pub-id_pmid">32612617</infon><infon key="section_type">REF</infon><infon key="source">Front. Immunol.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2020</infon><offset>50617</offset><text>The COVID-19 Cytokine Storm; What We Know So Far.</text></passage><passage><infon key="fpage">3977</infon><infon key="lpage">3990</infon><infon key="name_0">surname:Ren;given-names:X.</infon><infon key="name_1">surname:Wang;given-names:S.</infon><infon key="name_2">surname:Chen;given-names:X.</infon><infon key="name_3">surname:Wei;given-names:X.</infon><infon key="name_4">surname:Li;given-names:G.</infon><infon key="name_5">surname:Ren;given-names:S.</infon><infon key="pub-id_doi">10.2147/IDR.S270543</infon><infon key="pub-id_pmid">33177848</infon><infon key="section_type">REF</infon><infon key="source">Infect. Drug Resist.</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2020</infon><offset>50667</offset><text>Multiple Expression Assessments of ACE2 and TMPRSS2 SARS-CoV-2 Entry Molecules in the Urinary Tract and Their Associations with Clinical Manifestations of COVID-19.</text></passage><passage><infon key="fpage">611</infon><infon key="lpage">627</infon><infon key="name_0">surname:Rogers;given-names:J. P.</infon><infon key="name_1">surname:Chesney;given-names:E.</infon><infon key="name_2">surname:Oliver;given-names:D.</infon><infon key="name_3">surname:Pollak;given-names:T. A.</infon><infon key="name_4">surname:McGuire;given-names:P.</infon><infon key="name_5">surname:Fusar-Poli;given-names:P.</infon><infon key="pub-id_doi">10.1016/S2215-0366(20)30203-0</infon><infon key="pub-id_pmid">32437679</infon><infon key="section_type">REF</infon><infon key="source">Lancet Psychiatry</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2020</infon><offset>50832</offset><text>Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.</text></passage><passage><infon key="issue">102355</infon><infon key="name_0">surname:Sahoo;given-names:S.</infon><infon key="name_1">surname:Mehra;given-names:A.</infon><infon key="name_2">surname:Dua;given-names:D.</infon><infon key="name_3">surname:Suri;given-names:V.</infon><infon key="name_4">surname:Malhotra;given-names:P.</infon><infon key="name_5">surname:Yaddanapudi;given-names:L. N.</infon><infon key="pub-id_doi">10.1016/j.ajp.2020.102355</infon><infon key="pub-id_pmid">33271684</infon><infon key="section_type">REF</infon><infon key="source">Asian J. Psychiatr.</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="year">2020</infon><offset>51006</offset><text>Psychological experience of patients admitted with SARS-CoV-2 infection.</text></passage><passage><infon key="issue">604</infon><infon key="name_0">surname:Sindona;given-names:C.</infon><infon key="name_1">surname:Schepici;given-names:G.</infon><infon key="name_2">surname:Contestabile;given-names:V.</infon><infon key="name_3">surname:Bramanti;given-names:P.</infon><infon key="name_4">surname:Mazzon;given-names:E.</infon><infon key="pub-id_doi">10.3390/medicina57060604</infon><infon key="pub-id_pmid">34208136</infon><infon key="section_type">REF</infon><infon key="source">Medicina</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="year">2021</infon><offset>51079</offset><text>NOX2 Activation in COVID-19: possible implications for neurodegenerative diseases.</text></passage><passage><infon key="issue">e20202135</infon><infon key="name_0">surname:Song;given-names:E.</infon><infon key="name_1">surname:Zhang;given-names:C.</infon><infon key="name_2">surname:Israelow;given-names:B.</infon><infon key="name_3">surname:Lu-Culligan;given-names:A.</infon><infon key="name_4">surname:Prado;given-names:A. V.</infon><infon key="name_5">surname:Skriabine;given-names:S.</infon><infon key="pub-id_doi">10.1084/jem.20202135</infon><infon key="pub-id_pmid">33433624</infon><infon key="section_type">REF</infon><infon key="source">J. Exp. Med.</infon><infon key="type">ref</infon><infon key="volume">218</infon><infon key="year">2021</infon><offset>51162</offset><text>Neuroinvasion of SARS-CoV-2 in human and mouse brain.</text></passage><passage><infon key="fpage">2085</infon><infon key="lpage">2094</infon><infon key="name_0">surname:Soy;given-names:M.</infon><infon key="name_1">surname:Keser;given-names:G.</infon><infon key="name_2">surname:Atagündüz;given-names:P.</infon><infon key="name_3">surname:Tabak;given-names:F.</infon><infon key="name_4">surname:Atagündüz;given-names:I.</infon><infon key="name_5">surname:Kayhan;given-names:S.</infon><infon key="pub-id_doi">10.1007/s10067-020-05190-5</infon><infon key="pub-id_pmid">32474885</infon><infon key="section_type">REF</infon><infon key="source">Clin. Rheumatol.</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2020</infon><offset>51216</offset><text>Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.</text></passage><passage><infon key="issue">18</infon><infon key="name_0">surname:Sulzer;given-names:D.</infon><infon key="name_1">surname:Antonini;given-names:A.</infon><infon key="name_2">surname:Leta;given-names:V.</infon><infon key="name_3">surname:Nordvig;given-names:A.</infon><infon key="name_4">surname:Smeyne;given-names:R. J.</infon><infon key="name_5">surname:Goldman;given-names:J. E.</infon><infon key="pub-id_doi">10.1038/s41531-020-00123-0</infon><infon key="pub-id_pmid">32885037</infon><infon key="section_type">REF</infon><infon key="source">NPJ Parkinsons Dis.</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2020</infon><offset>51317</offset><text>COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside.</text></passage><passage><infon key="fpage">5</infon><infon key="lpage">24</infon><infon key="name_0">surname:Sutherland;given-names:L. C.</infon><infon key="name_1">surname:Rintala-Maki;given-names:N. D.</infon><infon key="name_2">surname:White;given-names:R. D.</infon><infon key="name_3">surname:Morin;given-names:C. D.</infon><infon key="pub-id_doi">10.1002/jcb.20204</infon><infon key="pub-id_pmid">15514923</infon><infon key="section_type">REF</infon><infon key="source">J. Cell. Biochem.</infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">2005</infon><offset>51413</offset><text>RNA binding motif (RBM) proteins: a novel family of apoptosis modulators?</text></passage><passage><infon key="fpage">2811</infon><infon key="lpage">2822</infon><infon key="name_0">surname:Sy;given-names:M.</infon><infon key="name_1">surname:Kitazawa;given-names:M.</infon><infon key="name_2">surname:Medeiros;given-names:R.</infon><infon key="name_3">surname:Whitman;given-names:L.</infon><infon key="name_4">surname:Cheng;given-names:D.</infon><infon key="name_5">surname:Lane;given-names:T. E.</infon><infon key="pub-id_doi">10.1016/j.ajpath.2011.02.012</infon><infon key="pub-id_pmid">21531375</infon><infon key="section_type">REF</infon><infon key="source">Am. J. Pathol.</infon><infon key="type">ref</infon><infon key="volume">178</infon><infon key="year">2011</infon><offset>51487</offset><text>Inflammation induced by infection potentiates tau pathological features in transgenic mice.</text></passage><passage><infon key="name_0">surname:Talairach;given-names:J.</infon><infon key="name_1">surname:Tournoux;given-names:P.</infon><infon key="section_type">REF</infon><infon key="source">Referentially Oriented Cerebral MRI Anatomy: An Atlas of Stereotaxic Anatomical Correlations for Gray and White Matter.</infon><infon key="type">ref</infon><infon key="year">1993</infon><offset>51579</offset></passage><passage><infon key="fpage">416</infon><infon key="lpage">427</infon><infon key="name_0">surname:Taquet;given-names:M.</infon><infon key="name_1">surname:Geddes;given-names:J. R.</infon><infon key="name_2">surname:Husain;given-names:M.</infon><infon key="name_3">surname:Luciano;given-names:S.</infon><infon key="name_4">surname:Harrison;given-names:P. J.</infon><infon key="pub-id_doi">10.1016/S2215-0366(21)00084-5</infon><infon key="pub-id_pmid">33836148</infon><infon key="section_type">REF</infon><infon key="source">Lancet Psychiatry</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2021</infon><offset>51580</offset><text>6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.</text></passage><passage><infon key="fpage">2574</infon><infon key="lpage">2576</infon><infon key="name_0">surname:Toscano;given-names:G.</infon><infon key="name_1">surname:Palmerini;given-names:F.</infon><infon key="name_2">surname:Ravaglia;given-names:S.</infon><infon key="name_3">surname:Ruiz;given-names:L.</infon><infon key="name_4">surname:Invernizzi;given-names:P.</infon><infon key="name_5">surname:Cuzzoni;given-names:M. G.</infon><infon key="pub-id_doi">10.1056/NEJMc2009191</infon><infon key="pub-id_pmid">32302082</infon><infon key="section_type">REF</infon><infon key="source">N. Engl. J. Med.</infon><infon key="type">ref</infon><infon key="volume">382</infon><infon key="year">2020</infon><offset>51722</offset><text>Guillain-Barré syndrome associated with SARS-CoV-2.</text></passage><passage><infon key="issue">121</infon><infon key="name_0">surname:Widyadharma;given-names:I. P. E.</infon><infon key="name_1">surname:Sari;given-names:N. N. S. P.</infon><infon key="name_2">surname:Pradnyaswari;given-names:K. E.</infon><infon key="name_3">surname:Yuwana;given-names:K. T.</infon><infon key="name_4">surname:Adikarya;given-names:I. P. G. D.</infon><infon key="name_5">surname:Tertia;given-names:C.</infon><infon key="pub-id_doi">10.1186/s41983-020-00258-0</infon><infon key="pub-id_pmid">33390724</infon><infon key="section_type">REF</infon><infon key="source">Egypt. J. Neurol. Psychiatr. Neurosurg.</infon><infon key="type">ref</infon><infon key="volume">56</infon><infon key="year">2020</infon><offset>51775</offset><text>Pain as clinical manifestations of COVID-19 infection and its management in the pandemic era: a literature review.</text></passage><passage><infon key="fpage">1015</infon><infon key="lpage">1016</infon><infon key="name_0">surname:Xydakis;given-names:M. S.</infon><infon key="name_1">surname:Dehgani-Mobaraki;given-names:P.</infon><infon key="name_2">surname:Holbrook;given-names:E. H.</infon><infon key="name_3">surname:Holbrook;given-names:E. H.</infon><infon key="name_4">surname:Geisthoff;given-names:U. W.</infon><infon key="name_5">surname:Bauer;given-names:C.</infon><infon key="pub-id_doi">10.1016/S1473-3099(20)30293-0</infon><infon key="pub-id_pmid">32304629</infon><infon key="section_type">REF</infon><infon key="source">Lancet Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2020</infon><offset>51890</offset><text>Smell and taste dysfunction in patients with COVID-19.</text></passage><passage><infon key="fpage">1444</infon><infon key="lpage">1448</infon><infon key="name_0">surname:Yan;given-names:R.</infon><infon key="name_1">surname:Zhang;given-names:Y.</infon><infon key="name_2">surname:Li;given-names:Y.</infon><infon key="name_3">surname:Xia;given-names:L.</infon><infon key="name_4">surname:Guo;given-names:Y.</infon><infon key="name_5">surname:Zhou;given-names:Q.</infon><infon key="pub-id_doi">10.1126/science.abb2762</infon><infon key="pub-id_pmid">32132184</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">367</infon><infon key="year">2020</infon><offset>51945</offset><text>Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.</text></passage><passage><infon key="fpage">665</infon><infon key="lpage">670</infon><infon key="name_0">surname:Yarkoni;given-names:T.</infon><infon key="name_1">surname:Poldrack;given-names:R. A.</infon><infon key="name_2">surname:Nichols;given-names:T. E.</infon><infon key="name_3">surname:Van Essen;given-names:D. C.</infon><infon key="name_4">surname:Wager;given-names:T. D.</infon><infon key="pub-id_doi">10.1038/nmeth.1635</infon><infon key="pub-id_pmid">21706013</infon><infon key="section_type">REF</infon><infon key="source">Nat. Methods</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2011</infon><offset>52023</offset><text>Large-scale automated synthesis of human functional neuroimaging data.</text></passage><passage><infon key="fpage">489</infon><infon key="lpage">496</infon><infon key="name_0">surname:Yarkoni;given-names:T.</infon><infon key="name_1">surname:Poldrack;given-names:R. A.</infon><infon key="name_2">surname:Van Essen;given-names:D. C.</infon><infon key="name_3">surname:Wager;given-names:T. D.</infon><infon key="pub-id_doi">10.1016/j.tics.2010.08.004</infon><infon key="pub-id_pmid">20884276</infon><infon key="section_type">REF</infon><infon key="source">Trends Cogn. Sci.</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2010</infon><offset>52094</offset><text>Cognitive neuroscience 2.0: building a cumulative science of human brain function.</text></passage><passage><infon key="fpage">98</infon><infon key="lpage">102</infon><infon key="name_0">surname:Zhou;given-names:H.</infon><infon key="name_1">surname:Lu;given-names:S.</infon><infon key="name_2">surname:Chen;given-names:J.</infon><infon key="name_3">surname:Wei;given-names:N.</infon><infon key="name_4">surname:Wang;given-names:D.</infon><infon key="name_5">surname:Lyu;given-names:H.</infon><infon key="pub-id_doi">10.1016/j.jpsychires.2020.06.022</infon><infon key="pub-id_pmid">32912598</infon><infon key="section_type">REF</infon><infon key="source">J. Psychiatr. Res.</infon><infon key="type">ref</infon><infon key="volume">129</infon><infon key="year">2020</infon><offset>52177</offset><text>The landscape of cognitive function in recovered COVID-19 patients.</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">title</infon><offset>52245</offset><text>Abbreviations</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>52259</offset><text>ABA</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>52263</offset><text>Allen Brain Atlas</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>52281</offset><text>AIBS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>52286</offset><text>Allen Institute for Brain Science</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>52320</offset><text>CNS</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>52324</offset><text>central nervous system</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>52347</offset><text>CoVs</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>52352</offset><text>coronaviruses</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>52366</offset><text>MNI</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>52370</offset><text>Montreal Neurological Institute</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>52402</offset><text>ORs</text></passage><passage><infon key="section_type">ABBR</infon><infon key="type">paragraph</infon><offset>52406</offset><text>olfactory receptors.</text></passage></document></collection>
